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Despite the estimate that more than half of the human proteome is glycosylated, 
the field of glycomics lags substantially behind proteomics and genomics. The ubiquity 
of carbohydrates in and on the cell is directly related to the extensive roles they play in 
the folding and stabilization of protein structure, and in cellular recognition processes. 
The slow progress in deciphering glycan interactions at a molecular level is in large part 
due to the absence of a functional system to express, on a large scale, carbohydrates of 
known structure, in the context of a biologically relevant assay system. The goals of my 
research are to prepare and characterize glycan-functionalized catanionic surfactant 
vesicles as a platform for glycan synthesis, and to demonstrate that the resulting glycan- 




To accomplish this goal, a high-yield method for the purification of N. 
gonorrhoeae lipooligosaccharide (LOS) glycosyltransferase LgtE, an enzyme that 
catalyzes the addition of galactose onto a terminal glucose found on LOS, was first 
optimized. Preliminary evidence is presented, suggesting that catanionic vesicles 
solubilize macromolecules found in inclusion bodies, indicating that surfactant vesicles 
facilitate the purification of insoluble species.  
A novel method exploiting differential lectin binding, measured by flow 
cytometry, was developed to demonstrate LgtE activity on whole cell bacteria and on 
catanionic vesicles functionalized with LOS or a synthetic glycolipid acceptor substrate. 
The data from these studies confirm the vesicles’ robustness in the highly sensitive assay, 
and demonstrates LgtE mediated oligosaccharide biosynthesis on vesicles, regardless of 
acceptor origin. Enzyme activity was then characterized on whole cells and LOS 
functionalized vesicles. Unexpectedly, LgtE is observed to have approximately the same 
affinity for both terminal glucose and galactose as acceptor substrates for galactosyl 
transfer. Finally, enzymatic synthesis and retention of the vesicles by hydrophobically 
modified chitosan coated electrodes is demonstrated by differential antibody binding.  
This dissertation presents proof-of-concept that glycan-functionalized catanionic 
vesicles can be used to create a high-specificity and high-throughput glycan array. This 
array will allow for the investigation of a variety of protein-glycan interactions, and will 
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Chapter 1: Introduction 
 
1.1 Introduction 
The term glycobiology was first coined in 1988 by the biochemist Raymond 
Dwek to recognize the linkage between carbohydrate chemistry and biochemistry.3 
Carbohydrates are the most abundant, naturally occurring biopolymers found in nature. 
All cells are covered in carbohydrate structures expressed as glycoconjugates, covalently 
coupled to lipids or proteins.4 A glycan can also exist as a free entity in, or be secreted 
by, cells.4 However, it was not until the 1970s and 1980s that an appreciation for the role 
of complex glycans in governing a variety of biological processes was demonstrated.5 
 Carbohydrates have critical roles in protein folding,6 cell adhesion,7 host-
pathogen interactions,8 cancer metastasis,9 activation and attenuation of innate and 
adaptive immunity,10, 11 and in cell signaling.3, 7 The diverse biological activity of 
carbohydrates is mediated through recognition by cognate proteins, termed glycan-
binding proteins (GBPs), triggering downstream effects.7 Little is known, however, about 
the structure-function relationships of carbohydrates, and how structure influences the 
ligand recognition by GBPs. Lack of mechanistic understanding of protein-carbohydrate 
interactions is a direct result of the inherent structural complexity of carbohydrates.5 
Carbohydrates are chains of polyhydroxyl aldehydes or ketones that can be 
hydrolyzed into monosaccharides.4 Glycosyl groups, cyclic monosaccharides lacking the 
hydroxyl group of the hemiacetal or hemiketal carbon, are linked together by a glycosidic 
bond, either α or β, depending on the orientation with respect to the anomeric carbon of 
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the reducing sugar. Linkage results in oligo- and polysaccharide structures, forming 
extended hydrated chains (Figure 1.1). 
Polysaccharides are more structurally diverse than amino and nucleic acids. A 
consequence of the many regio- and stereochemistries possible with the furanose and 
pyranose rings is a branched polysaccharide structure.12 Illustrating this structural 
complexity, three nucleotides or amino acids can generate just six different trimers, 
whereas three different hexoses can generate anywhere from 1,056 to 27,648 distinct 
trisaccharides.4 Further increasing the diversity of carbohydrate structure, a hydroxyl of a 
glycoside can be substituted with a variety of functional groups. For example, a hydroxyl 
can be replaced with a hydrogen atom to form a deoxy sugar, or with an acetyl group or 
an amino group forming an acetyl sugar or an amino sugar, respectively, among others.13  
A major challenge facing the field of glycomics is a lack of methodology for in 
vitro carbohydrate synthesis. In vitro isolation of glycans from glycoconjugates is 
complicated by microheterogeneity.4 The glycosylation site on a protein expressed in a 
cell can have a variety of carbohydrates attached to it. Therefore, isolation of 
homogenous glycan moieties is rarely accomplished.14 Organic synthesis of 
polysaccharides is complicated by protective group chemistry of the free hydroxyls, a 
necessary measure to distinguish one hydroxyl from another, and by the liability of the 
 
Figure 1.1. Glycosidic bond synthesis. The leaving group (X) on the anomeric carbon of the 
donor is displaced due to a nucleophilic attack by the alkoxy group on the acceptor moiety. R 
and R’ in this figure are non-participating groups. Figure adapted from reference 13. 
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glycosidic bonds (Figure 1.1),15 requiring multiple synthetic steps and generating mixed 
anomers of low yield.5 
Carbohydrates are not encoded in an organism’s genome, but are synthesized 
through sequential enzymatic reactions catalyzed by glycosyltransferases that recognize a 
specific glycan structure.3 Glycosyltransferases (EC 2.4.x.y) are present in both 
eukaryotes and prokaryotes and catalyze the transfer of an activated sugar moiety onto a 
growing carbohydrate chain generally with high regio- and stereospecificity, generating 
significant yields of the defined glycosidic linkages.14 The Carbohydrate-Active Enzyme 
(CAZy) Database (www.cazy.org), maintained by Université de Provence/ Université de 
la Méditerranée, Marseille, France, has cataloged over 200 families of 
glycosyltransferases, along with other carbohydrate-active enzymes.14 
Glycosyltransferases catalyze the formation of glycosidic linkages between a 
donor and an acceptor molecule. The acceptor can be another saccharide, a lipid, or a 
protein.14 All glycosyltransferases can be grouped according to their preferential donor 
substrate as belonging to the Leloir or non-Leloir pathway. Additionally, they are sub-
classed as either retaining or inverting based on if the glycosidic bond has α or β 
stereochemistry with respect to anomeric configuration of the product to the donor 
substrate.6  
 Enzymes of the Leloir pathway utilize sugar nucleotides as a donor substrate. 
Non-Leloir glycosyltransferases utilize phosphorylated monosaccharides (i.e. dolichol 
phosphomannose), as the donor substrate. Leloir pathway glycosyltransferases 
predominate over their non-Leloir counterparts, due to the inherent chemical properties 
that make sugar nucleotides ideal donor substrates.14 Sugar nucleotides are synthesized in 
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a multistep metabolically irreversible process in which a kinase activates a specific 
monosaccharide. The phosphorylated monosaccharide is further activated by a nucleotide 
transferase/phosphorylase through a condensation reaction, typically with uridine-
triphosphate.6 The formation of the glycosidic bond between the donor and a specific 
hydroxyl in the acceptor, with a free energy of approximately +16 kcal/mol, is driven by 
the hydrolysis of the donor precursor and is facilitated by the strong leaving group nature 
of the nucleotide diphosphate.14  
Increased recognition of the diverse roles carbohydrates play in biology suggests 
that glycosyltransferases could be exploited for the in vitro synthesis of complex 
carbohydrates.14, 16 Glycosyltransferase reactions are typically carried out in aqueous 
solutions at a physiological pH.5 They have high regio- and stereoselectivity, eliminating 
the need of protecting and deprotecting groups. Emphasizing the potential exploitation of 
glycosyltransferases, Toone et al. has stated that no other class of organic compounds is 
more amenable to enzymatic synthesis than carbohydrates.5 Mammalian 
glycosyltransferases are typically transmembrane proteins with low solubility, 
complicating protein purification. Alternatively, bacterial glycosyltransferases are 
noncovalently associated with cellular membranes making them attractive candidates for 
in vitro synthesis.  
To advance the molecular understanding of the biological roles of carbohydrates, 
a method for the facile expression and purification of recombinant glycosyltransferases 
must be developed. A related but equally important requirement is the development of 
appropriate assay tools to investigate protein-carbohydrate interactions. 
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1.2 Glycomic Array 
Glycan binding proteins mediate a variety of biological responses. Protein-
carbohydrate interactions are dependent on the spatial orientation and density of ligand 
presentation.17 Generally, glycan binding proteins have weak monovalent interactions 
with their cognate ligand, the monomeric dissociation constant (KD) being in the 
millimolar range.18 High affinity ligand recognition is accomplished through multivalent 
interactions of multiple glycan binding domains.17, 18 Ligand presentation is important in 
establishing these multivalent complexes. However, investigating these interactions is 
limited by the availability of homogenous carbohydrate structures. 
Arrays have been previously developed employing a variety of platforms to which 
glycans are covalently or noncovalently immobilized.19 These platforms include silica 
plates,20 glass slides,21 nitrocellulose,22 and the immobilization of neoglycoconjugates.23 
While each has provided researchers a means to investigate protein-carbohydrate 
interactions, reproducibility of protein binding profiles remains elusive. Variations in 
ligand density and orientation, in the physical properties of the platform such as surface 
charge, and length and flexibility when a linker is used to facilitate glycan surface 
attachment, can all significantly influence protein binding.17, 23, 24 There is a pressing need 
in the field of glycomics for the development of an array platform in which carbohydrates 
are easily immobilized and presented for protein binding, and in which ligand density can 




1.3 Surfactant Aggregates 
The term surfactant describes amphiphilic molecules that are surface active 
agents that partition at water: air or polar: non-polar interfaces (Figure 1.2A). Common 
surfactants are commercially available in detergents, soaps, and emulsifiers. Like 
phospholipids of cell membranes, surfactants are composed of a long single or double 
non-polar alkyl tail and a polar head group. The chemical properties of the head group 
serve as a means of classification. Non-ionic surfactants, such as octyl phenol ethoxylate 
(Triton X-100), are composed of an uncharged but highly polar head group. Ionic 
surfactants can be further grouped as cationic, such as cetyltrimethylammonium bromide 
(CTAB), if the polar head group has an overall positive charge, or anionic if it has an 
overall negative charge. A common anionic surfactant is sodium dodecylsulfate (SDS). 
Zwitterionic surfactants carry both a negative and positive charge. Two of the most 
abundant phospholipids in the mammalian cell bilayer, phosphatidylcholine and 
phosphatidylethanolamine, are zwitterionic.  
Amphiphilic molecules in solution will spontaneously self-assemble into colloidal 
aggregates. Micelles and bilayer vesicles are equilibrium structures that form upon 
rearrangement of amphiphilic molecules, so as to reduce the exposure of the hydrophobic 
tail to the aqueous environment. Amphiphile rearrangement is thermodynamically driven 
 
Figure 1.2. A. Surfactants partition at water: air or polar: non-polar interfaces B. Cartoon 
depiction of a micelle formed from a single-tailed surfactant C. Cartoon depiction of a 
unilamellar bilayer vesicle. 
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by the hydrophobic effect, such that spontaneous self-assembly into aggregates 
minimizes the free energy of the system. Micelles are the simplest form of a self-
assembled structure, with the polar head groups exposed to the exterior environment and 
the non-polar tails sequestered in the center. Vesicles form when a planar bilayer assumes 
curvature. They can be unilamellar, consisting of a single bilayer, or can contain more 
than two monolayers, in which case a multilamellar structure forms. The type of 
aggregate that forms is dependent on the size, shape, and charge of the amphiphilic 
molecule. These characteristics are collectively termed an amphiphile’s molecular 
geometry. 
Israelachvili first described the relationship between an amphiphile’s geometry to 
the predicted aggregation structure in 1976.25  The geometry of a surfactant molecule can 





      (Equation 1.1) 
where v is the volume of the hydrocarbon tail, ao is the effective area of the hydrophilic 
head group, and l is the critical length of the hydrocarbon chain. The packing parameter 
value can be thought of as a measure of membrane curvature, surfactant molecules with 
smaller packing parameters are predicted to have a more highly curved aggregate 
structure.26  
Amphiphiles with a large head group area and a small hydrocarbon tail volume 
have a packing parameter value of less than 1/3 and are entropically driven to form 
spherical micelles. Amphiphiles with a smaller ao or larger v have a packing parameter 
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value in the range of 1/3 to 1/2 and form cylindrical micelles. Cylindrical amphiphiles 
have a packing parameter that equals approximately 1. These molecules cannot pack into 
a small micellar structure, rather the molecules aggregate into planar bilayers. For 
amphiphiles to form a bilayer, the ao and chain length being the same, the v must be 
approximately twice that of a micellar-amphiphile. Bilayers, however, are not 
thermodynamically stable due to the presence of energetically unfavorable edges. To 
eliminate the edges, fusion of the bilayer ends occurs and vesicles are formed (Table 1.1). 
 
Table 1.1. Mean packing parameters of amphiphilic molecules and the predicted aggregate 
structures. Adapted from reference 26.  
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In a single surfactant system the packing parameter value allows for the prediction 
of aggregate structure with a high degree of certainty. In mixed surfactant systems with 
more than one amphiphile present in solution, the packing parameter for the individual 
surfactants cannot provide an accurate prediction. An understanding of the 
thermodynamics of self-assembly, and a description of how the aggregates form, 
provides an explanation for this discrepancy.   
Spontaneous formation and stability of equilibrium structures is determined by the 
thermodynamics of self-assembly, intra-aggregate forces, as well as inter-aggregate 
forces. It is important to note that the equilibrium structures, such as micelles, formed 
upon amphiphile aggregation are not static entities. They are in constant thermal motion  
within an aggregate and are in equilibrium between the aggregate and dispersed 
monomers (Figure 1.3).25  
The type of colloidal aggregate formed in solution is based on the anisotropic 
binding forces acting between different parts of the amphiphilic molecules. The 
hydrophobic tails give rise to attractive interfacial tension forces. In contrast, the 
amphiphilic molecules experience repulsive forces due to steric and electrostatic 
 
Figure 1.3. The association of monomer into equilibrium aggregate structures. The 
association and dissociation constants of aggregate formation are denoted as k1 and kN 




contributions of the hydrophilic head group. The opposing forces dictate that micelle 
formation will only occur above a certain monomer concentration. The concentration of a 
particular amphiphile at which the monomers no longer behave as isolated entities is 
denoted the critical micelle concentration (CMC). Below the CMC only monomers are 
present in solution. Above the CMC, amphiphiles spontaneously form self-assembled 
structures and further addition of amphiphiles results in the formation of more 
aggregates, leaving the monomer concentration constant. The mean aggregation number, 





                     (Equation 1.2) 
where S is the total surfactant concentration and M is the concentration of micelles in the 
system.  
 Accounting for both the attractive and repulsive forces involved in micelle self-
assembly, the interaction free energy of molecules, 𝜇𝑁
0 , in an aggregate of aggregation 






   (Equation 1.3) 
where 𝜇∞
0  is the chemical potential of a molecule in an aggregate of infinite aggregation 
number. P is the packing parameter previously described in equation 1.1, k is the 
Boltzmann constant, and T is the temperature in Kelvin. α is a positive constant that 
depends on the strength of the intermolecular interactions in the aggregate. α can be 







    (Equation 1.4) 
where r is the effective radius of the amphiphilic molecule, and γ is the interfacial free 
energy per unit area of a molecule. The term, αkT, in equation 1.3 describes the 
monomer-monomer interaction energy in an aggregate relative to isolated free monomers 
in solution. Equation 1.3 dictates that 𝜇𝑁
0  decreases asymptotically towards 𝜇∞
0  as N 
increases. This mathematical relationship implies that in a system there is a finite 
minimum value of N where the free energy of interaction is minimized. The inverse 
relationship between the free energy of interaction and the aggregation number is 
necessary for spontaneous self-assembly, as the negative free energy difference 
thermodynamically drives aggregation (Figure 1.3). 
1.4 Catanionic Surfactant Vesicles 
 Bangham et al. first described vesicles in 1964 with the observation that double 
tailed phospholipids in an aqueous solution self-assemble into multilamellar vesicle 
aggregates, later termed liposomes.27 This research led to the understanding that 
phospholipids are the permeability barrier of all eukaryotic cells.28 Unilamellar 
phospholipid derived liposomes have since been extensively researched and described as 
both a cell membrane model and as a method for drug delivery.29 Phospholipid molecules 
however have a packing parameter of 1. The geometry of phospholipids favors the 
formation of planar bilayer colloidal aggregates. Unilamellar liposome formation is not 
thermodynamically favored. To induce the formation of monodispersed vesicles, an input 
of mechanical energy is required, such as sonication or extrusion through a filter.30 
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Liposomes are therefore metastable, bilayer integrity is maintained for an average of two 
days.30  
In 1989, Kaler et al. demonstrated the spontaneous formation of unilamellar 
vesicles in an aqueous mixture of two single-tailed surfactants with oppositely charged 
head groups.31 The cationic surfactant in the system is cetyltrimethylammonium tosylate 
(CTAT), with a cetrimonium cation head group and a tosylate counter ion (Figure 1.4A). 
Sodium dodecylbenzene sulfonate (SDBS), with an anionic sulfonate head group and 
sodium counter ion (Figure 1.4B), is the anionic surfactant in the system. The 
cationic/anionic, or catanionic, surfactant vesicles are more stable than phospholipid-
derived liposomes. Studies conducted by Kaler et al. and by other groups observed that 
catanionic vesicles maintained bilayer integrity for over a year at room temperature.31, 32 
Moreover, the degree of bilayer curvature, as well as the magnitude of surface charge, or 
 




zeta potential, could be readily varied by changing the proportions of the individual 
surfactants and/or the addition of nonionic surfactants.31  
The observation by Kaler et al. that aqueous mixtures of CTAT and SDBS 
spontaneously form unilamellar catanionic vesicles was unexpected. In contrast to 
aggregates composed of double tailed amphiphiles with a packing parameter of 1, single 
tailed surfactants are not expected to form bilayer structures. CTAT and SDBS both have 
packing parameters of approximately 1/3, predicting micellar aggregates. Experimental 
observations by Kaler and co-workers confirmed that SDBS formed spherical micelles in 
an aqueous solution whereas CTAT formed cylindrical micelles. When mixed together at 
the appropriate concentrations unilamellar vesicles formed.31 
 The mechanism underlying spontaneous catanionic vesicle formation has been 
previously reported.33 Koehler et al. examined the physical properties of the CTAT/ 
SDBS mixed surfactant system and constructed a phase diagram based on the behavior of 
the surfactants at various concentrations (Figure 1.5).33 Significantly, catanionic vesicles 
will only form in solution if either the cationic or the anionic surfactant is in molar excess 
of the other. Specifically, a weight ratio of ~70/30 is critical for the formation of 
catanionic vesicles, outside this region two-phase structures or precipitation occurs. 
It is clear from the work of Kaler et al., Koehler et al., and other groups that the 
SDBS/CTAT mixed surfactant system behaves differently than the individual surfactants 
alone in solution.31, 33 Spontaneous self-assembly of SDBS and CTAT into vesicle 
aggregates, can be explained by electrostatic interactions between the two ionic head 
groups. Aggregate formation and stability is dependent on a balance of the attractive and 
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repulsive forces involved in monomer-monomer interaction.25 In the mixed surfactant 
system, the cationic head group, CTA+, and the anionic, DBS-, head group can physically 
associate to form ion pair complexes. Ion pairs mimic the geometry of double-tailed 
zwitterionic phospholipids, as illustrated in figure 1.6A. These pseudo-double-tailed 
surfactants have an increased hydrocarbon tail volume and a decreased average head 
group area, such that the packing parameter increases from ~ 1/3 for the individual 
surfactants to approximately 1/2 - 1,34 and predicts a curved bilayer aggregate.  
Ion pair complexes explain the formation of bilayers, and vesicles were 
previously described as curved bilayers that fuse in order to eliminate energetically 
unfavorable ends.25 A model describing the spontaneous curvature of bilayer vesicles 
composed of two ionic surfactants that individually form micelles was proposed by 
 
Figure 1.5. Phase diagram of the CTAT/SDBS system in water. Rod-like micelles are formed 
in the CTAT-rich corner (R). Region I and II are micelle/vesicle two-phase regions. At higher 
SDBS concentrations spontaneous vesicles (V) and lamellar structures (Lα) form. In the 
SDBS-rich corner micelles (M) are observed. The CTAT and SDBS-rich vesicles lobes are 
denoted at V+ and V- respectively. The numbers on the outside of the pyramid designate 




Safran et al.35 In the model, equilibrium vesicles of an ideal radius are stabilized by 
curvature energy that arises from mixing two surfactants. Mixing allows the formation of 
monolayers with different concentrations of the surfactants (Figure 1.6B). Differing 
monolayer composition, together with the formation of ion pairs, results in monolayers 
with equal but opposite curvature.35  
To describe the free energy that stabilizes unilamellar vesicle formation, Safran et 
al. begin with a vesicle containing two oppositely charged surfactants, surfactant 1 and 
surfactant 2. The vesicle’s inner monolayer has a composition, ci, which is different from 
the outer monolayer, co. The curvature elastic energy of the vesicle per unit area, fc, can 
be determined from the equation: 
𝑓𝑐 = 2𝐾[(𝑐 + 𝑐𝑜)
2 + (𝑐 + 𝑐𝑖)
2] 
 (Equation 1.5) 
where c is the bilayer curvature and K is the bending elastic modulus. The asymmetrical 
distribution of surfactants to each monolayer influences the surfactant packing density in 
each monolayer.35 If the hydrophobic tails of both surfactants are the same length, the 
 
Figure 1.6. A. Illustration of the ion pair complex that forms between the cationic head group 
CTA+, and the anionic head group DBS-. B. Cross-section of SDBS-rich vesicle bilayer. The 





curvature of each monolayer is dependent on the bond distances between the polar head 
groups of the monolayer. As illustrated in figure 1.6A, the formation of ion pairs 
decreases the effective head group area of the surfactant molecules, decreasing the bond 
distance between two molecules. The curvature elastic energy is minimized at a finite 
curvature of ci=-co, which can only occur if there are attractive interactions that stabilize 
the vesicle and impart a positive (ci>0) curvature to the inner monolayer. The outer 
monolayer must have an equal, but negative (co<0), curvature, achieved in catanionic 
vesicular systems by partitioning the excess surfactant to the outer monolayer.31, 35 
Therefore, the SDBS-rich vesicles employed in this work spontaneously form unilamellar 
vesicles with an excess negative charge on the outer monolayer (Figure 1.6B).  
The excess charge of catanionic surfactant vesicles imparts important physical 
properties. It is a repulsive inter-aggregate force, giving vesicles superior colloidal 
stability as compared to liposomes. Studies conducted in the DeShong laboratory as well 
by other groups have demonstrated that catanionic surfactant vesicles are stable for years 
at room temperature.32, 36 Additionally, the surface of catanionic vesicles can be 
decorated with glycans conjugated to hydrophobic moieties.32, 37 In this case, the 
hydrophobic tail of the glycoconjugate spontaneously inserts into the vesicle outer leaflet 
and anchors the glycan to the outer surface of the vesicle (Figure 1.7). Recent also studies 
indicate that catanionic surfactant vesicles can be immobilized on a variety of surfaces, 
and that the incorporated moieties are recognized by ligand specific proteins.37, 38   
The thermodynamic principles outlined in this discussion as well as the other 
briefly mentioned studies led to the hypothesis that catanionic surfactant vesicles could 
be employed as a novel platform for investigating protein-glycan interactions. The 
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superior stability, facile preparation, and the low cost of the individual surfactants make 
the SDBS/CTAT system an ideal option for in vitro studies. This work investigates the 
utility of SDBS-rich catanionic vesicles as a platform for the in vitro biosynthesis of 
oligosaccharides. SDBS-rich vesicles have a surface charge of -35-70 mV, a value 
comparable to the zeta potential of a Gram-negative bacteria cell.37 Therefore, a 
glycosyltransferase that in vivo modifies glycans presented on the inner bacterial cell 
membrane could, in principle, catalyze the transfer of a donor sugar to an acceptor 
molecule presented on the surface of a surfactant vesicle. The next section will describe 
the introduction of a bacterial oligosaccharide into the leaflet of catanionic vesicles, and 
the utilization of the resulting glycan-functionalized vesicles as a substrate for a 
glycosyltransferase. This system serves as a model for in vitro carbohydrate 
investigations and synthesis.  
1.5 Lipidated Glycans of Bacteria 
Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-
negative bacteria and is essential for viability.3 It is composed of three sequential regions: 
 
Figure 1.7. Incorporation of amphiphilic glycoconjugates into the outer leaflet of catanionic 
vesicles.   
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the lipid A domain, a nonrepeating core oligosaccharide region, and the O-antigen 
polysaccharide (Figure 1.8). Lipid A is a hydrophobic moiety that is essential for outer 
membrane integrity and for cell viability. It is a potent immune modulator, recognized by 
 
Figure 1.8. General structure of LPS. Sequentially: lipid A (green), inner core (blue), outer 




the toll-like receptor 4 (TLR4) triggering inflammation.39 Attached to the lipid A moiety 
is the core oligosaccharide region, composed of the inner and outer core. The inner core 
consists of monosaccharides unique to prokaryotes including the acidic 3-deoxy-D-
manno-oct-2-ulosonic acid (KDO) and L-glycero-D-mannoheptose (L,D-Hep).39 
Additionally, the inner core glycans can be decorated with phosphates or 
phosphorylethanolamine (PEtN), which modulate the charge and conformation of the 
structure.3, 39, 40 The outer core displays more structural diversity than the inner core, but 
this variation appears to be limited within a particular genus and species of bacteria.39 
In many non-mucosal Gram-negative bacteria, including Enterobacteriaceae, 
Pseudomonadaceae, Pasteurellaceae, and Vibrionaceae, the outer core in the nascent 
lipid A-core LPS molecule serves as the acceptor for a long repeating polysaccharide 
known as the O-antigen.39 The O-antigen is structurally diverse, with more than 60 
monosaccharides identified as components.39 Further amplifying the diversity are 
variations in glycosidic linkages and non-carbohydrate substitutions. The heterogeneity 
of expressed LPS molecules modulate a bacterium’s infectivity and fitness through a 
number of mechanisms. A particular LPS structure can impart resistance to cationic 
antimicrobial peptides,41 facilitate the evasion of complement-mediated cell lysis,42 and 
influences bacterial binding to host cell receptors.39  
Lipooligosaccharide (LOS) is a structural variant of LPS that terminates at the 
outer core region (Figure 1.9). LOS is found on mucosal pathogens such as Bordetella 
pertussis, Haemophilus influenza, Neisseria gonorrhoeae, and N. meningitidis.43 In 
contrast to LPS, LOS can be branched with one to three oligosaccharide chains extending 
from the inner core heptose molecules. LOS, like LPS, is immunogenic, and in the case 
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of N. gonorrhoeae is responsible for uterine scarring, predisposing females to the 
development of ectopic pregnancies and infertility.44  
The outer core of LOS exhibits a high degree of inter- and intra-strain variability 
due to the selective pressures of host environment and immune response.39  N. 
gonorrhoeae LOS displays considerable antigenic variation, and distinct structural 
variants are often simultaneously expressed on the same bacterium.45, 46 Exemplifying the 
extreme heterogeneity of LOS, a strain of N. gonorrhoeae isolated from a patient with 
 
Figure 1.9. Diagram of N. gonorrhoeae LOS. The incorporated monosaccharides are 
indicated in red. The glycosyltransferases responsible for glycosidic bond formation are 




pelvic inflammatory disease (PID) was determined to simultaneously express six 
different LOS epitopes on a single cell.47 Monoclonal antibody binding studies indicate 
that N. gonorrhoeae LOS antigenic variation occurs at a frequency of 10-2-10-3, indicating 
a genetic regulatory mechanism.45  LOS structural modulation can influence Neisseria 
interactions with host tissues and can direct the course of infection.46  
The outer core structure of N. gonorrhoeae LOS often mimics human 
glycosphingolipids. For example, the LOS epitope lacto-N-neotetraose (Galβ1-
4GlcNAcβ1-3Galβ1-4Glc) found on N. gonorrhoeae mimics human paragloboside, a 
glycosphingolipid expressed on human red blood cells.43 The addition of N-
acetylgalactosamine to lacto-N-neotetraose (GalNAcβ1-3 Galβ1-4GlcNAcβ1-3Galβ1-
4Glc) is often observed in wild-type Neisseria LOS and mimics human gangliosides.45 
The ability of Neisseria to mimic human glycans is not only a mechanism by which the 
organism can evade the host immune response, but is also a means to exploit exogenous 
molecules from the host that associate with the mimicked glycan.46 Apicella et al. 
determined that the lacto-N-neotetraose LOS epitope bound asialoglycoprotein receptors 
(ASGP-R) expressed on primary human urethral epithelial cells, promoting endocytosis 
and facilitating infection of host tissues.48  
LOS can also influence a host’s response to infection. LOS is the target for 
bactericidal activity of human sera in individuals suffering from gonorrhea.49 Bactericidal 
activity is an innate immune response induced by complement-mediated cell lysis.50 N. 
gonorrhoeae can resist complement mediated killing by sialyation of its LOS in vivo.45, 50 
The gonococcus expresses an α-2-3-sialytransferase on its outer membrane and uses 
exogenous cytidine-monophosphate N-acetylneuraminic acid (CMP-NANA) from the 
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host as a donor substrate.8 While sialic acid deposition affords serum resistance, it also 
reduces the bacterium’s ability to invade epithelial tissues.45, 46 LOS antigenic variation, 
therefore, increases N. gonorrhoeae fitness in vivo by allowing the gonococcus to switch 
from an invasive to a serum-resistant phenotype depending on environmental stimuli. 
Distinct glycoforms appear to be favored at different stages of infection.12, 44 The 
exact causes of this selective pressure and their influence on host: pathogen interactions 
remain undefined. The ambiguity is in large part due to the fact that in vitro 
investigations of LOS and the conjugate glycan binding proteins remains a challenge 
because of the insolubility of the lipid A moiety.14 LOS binding proteins are often 
determined in the context of a synthetic LOS structure,15, 51 in a whole cell background,2 
or on O-deacylated LOS.14 To fully elucidate the influence of LOS structure in Neisseria 
pathogenesis, a platform devoid of other bacterial outer membrane components, but that 
mimics the bacteria cell in charge, outer membrane composition, and presents the glycan 
in a biologically relevant manner, is necessary. SDBS-rich catanionic surfactant vesicles 
meet these requirements and could be used as a N. gonorrhoeae cell mimic. We 
hypothesized that catanionic vesicles decorated with LOS would present the glycan in 
such a way that the glycan would serve as a substrate for bacterial glycosyltransferases. 
1.6 LOS Biosynthesis 
The glycan component of Neisseria LOS is synthesized by the protein products of 
seven lipooligosaccharide glycosyl transferase (lgt) genes. Five genes, lgtABCDE, are 
clustered in a single locus in the Neisseria chromosome. The lgt locus has been 
characterized genetically by the Stein Lab as well as other groups.44, 45, 52, 53 Gotschlich 
determined that the lgtA, lgtC, and lgtD genes in N. gonorrhoeae contained runs of 
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guanine within the coding sequence of these genes, termed poly-G tracts.45 These poly-G 
tracts are a mechanism of phase variation, allowing for strand slippage during DNA 
replication, ultimately resulting in in-frame or out-of-frame transcripts. Further studies 
demonstrated a N. gonorrhoeae strain that had lgtA frame shifted to the “off” position, 
continued to synthesize a basal level of LgtA positive LOS structures.44, 52 The 
observation was explained by translational strand slippage of the ribosome on the out of 
frame mRNA, resulting in an in-frame protein product. Braun et al. demonstrated that 
there are multiple promoters within the lgtABCDE locus eliciting complex transcriptional 
control, with limiting concentrations of LgtA, LgtB, LgtC, LgtD, and LgtE being made.  
This results in the production of multiple LOS structures.44 These observations indicate 
that the glycosyltransferases involved in LOS biosynthesis are extremely efficient. The 
translational products act sequentially to synthesize the full-length α-chain, as well as the 
alternate α-chain (Figure 1.9). The lgtA gene encodes for a β-1,3-N-
acetylglucosaminyltransferase, whereas lgtD encodes a β-1,4-N-
acetylglucosaminyltransferase. LgtA and LgtD both utilize UDP-N-acetylglucosamine as 
a donor substrate. lgtB and lgtE encode β-1,4-galactosyltransferases, both utilizing the 
common donor substrate UDP-D-galactose. The middle open reading frame in the 
cluster, lgtC, encodes a α-1,4-galactosyltransferase. 
Another property of the lgt operon is the high degree of homology between the 
lgtA and lgtD genes and between the lgtB and lgtE genes.45 The amino acid sequence of 
the gene pairs is nearly identical in the amino-terminus, but diverges towards the 
carboxyl-terminus.45 The observed sequence homology and divergence is explained by 
the activities of these gene products. These gene pairs encode for glycosyltransferases 
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that utilize the same donor substrate, UDP-GlcNAc and UDP-Gal, respectively. The 
lgtABDE sequence analysis suggests that the N-terminus of these Leloir 
glycosyltransferases is responsible for donor substrate binding, whereas the C-terminus 
imparts acceptor substrate binding specificity.  
Following the identification of the LOS biosynthetic genes, numerous groups 
have characterized the protein products. Coding sequences for LgtA, LgtB, LgtC, and 
LgtE have been cloned and expressed in E. coli, and subsequently purified.2, 15, 44, 54 The 
kinetic parameters of LgtA, LgtB, and LgtC for various synthetic acceptors have also 
been determined. For LgtC the KM(app) for the acceptor substrate p-nitrophenol-β-D-
lactoside was determined to be 1.4 ± 0.1 mM.15 LgtA had a similar Km(app), 4.3 mM, for 
the same substrate.54 LgtB was determined to have a KM(app) for p-nitrophenol N-acetyl- 
β-D-glucosaminide of 0.6 ± 0.1 mM.15 The implication of these KM(app) values in the 
millimolar range is that the enzymes appear to have low affinity for the acceptor 
substrate. The conclusion from the biochemical data, however, contradicts the in vivo 
observations that minimal concentrations of these enzymes are needed to synthesize the 
corresponding LOS.  
Further discrepancies arise in studies examining the in vitro activity of LgtE. An 
early study did not observe LgtE activity on p-nitrophenol N-acetyl-β-D-glucosaminide, 
and concluded that the enzyme had stringent acceptor specificity, requiring the terminal 
glucose to be linked to a heptose molecule as in LOS.14 Work conducted by Piekarowicz 
et al., however, indicated that LgtE had flexible acceptor substrate specificity, mediating 
the transfer of galactose to both glucose terminal and galactose terminal whole cell LOS 
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structures.2 It is clear from these inconsistent observations that the acceptor substrate 
presentation influences LgtE activity. 
The work of this dissertation focuses on the exploiting the unique biochemical 
properties of LgtE. Previous studies indicate that the enzyme is extremely efficient in 
vivo,44 however, the in vitro activity appears to be exquisitely sensitive to substrate 
presentation.14 LgtE, therefore, is uniquely qualified as a model enzyme to examine the 
utility of catanionic surfactant vesicles as a platform for oligosaccharide biosynthesis.  
  LgtE is an inverting galactosyltransferase that mediates the transfer of a galactose 
moiety on to a terminal glucose LOS acceptor molecule (Figure 1.10). The in vitro 
synthesis of oligosaccharides onto a terminal glucose has wide-spread applicability as 
many prokaryotic glycoconjugates have a terminal glucose containing disaccharide.55  
 
Figure 1.10. ΔlgtA truncated LOS structure. LgtE catalyzes the finally step in the 




LgtE is a member of the glycosyltransferase GT-A family based on predicted 
structure.12 GT-A enzymes contain two domains positioned in close proximity to each 
other. Both domains have a Rossmann-like fold, consisting of an α helix/ β sheet/ α helix 
sandwich.56 The Rossmann fold is characteristic of nucleotide binding proteins. One 
domain is attributed to the sugar nucleotide-binding cleft and the other is the acceptor-
binding pocket.6 The central β sheet of one domain, together with a flanking β sheet from 
the other domain, forms the active site of the enzyme. Within the sugar nucleotide-
binding domain of LgtE is the conserved DXD amino acid motif. This motif coordinates 
a divalent metal ion cofactor, Mn2+, electrostatically stabilizing the increasing negative 
charge on the nucleotide diphosphate leaving group during the reaction.6, 14 
LgtE is further grouped into the β-1,4-galactosyltransferase subfamily GT-25. 
These enzymes have an additional conserved aspartic or glutamic acid residue in their 
active site that acts as a base which catalyzes the deprotonation of the acceptor substrate 
for a double displacement, SN2-type, nucleophilic attack at the C1 position of the 
nucleotide sugar donor (Figure 1.11).6, 14 Weijers et al. demonstrated that the transition 
state is an oxocarbenium ion-like intermediate formed by the donor sugar, the nucleotide 
diphosphate, and the acceptor moiety. The final product results from the addition of a 
monosaccharide to the acceptor substrate with the formation of a β-glycosidic bond.14   
LgtE, along with the other enzymes involved in LOS biosynthesis, sequentially 
add sugars to the growing LOS molecule in a process analogous to an assembly line. 
LgtABCDE enzymes exist in vivo as an inner membrane protein complex,39 
noncovalently associated with the membrane via pairs of basic residues in the carboxyl-
terminus.15 Lipid A of the nascent LOS molecule is also incorporated into the inner 
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membrane with the inner core sugars extending into the cytoplasm.39 The physical 
proximity of the protein complex and nascent LOS molecule increases the effective 
acceptor substrate concentration, and may explain the high efficiency of 
glycosyltransferase activity observed in vivo44 that is not observed in vitro.14 
1.7 Research Objectives  
Despite the ubiquity of carbohydrates in nearly all facets of life, to date a facile 
method of synthesizing complex carbohydrates and investigating their interactions with 
cognate glycan binding proteins has not been reported. To address this issue, the primary 
aim of this dissertation is to demonstrate that recombinant glycosyltransferases can 
synthesize glycans of known structure on a catanionic surfactant vesicle platform, and 
that specific protein- glycan interactions can be examined in this context. This will form 
the basis for the development of high-throughput glycomic array technology, which is 
imperative for advancement in the field of glycomics. The work presented herein 
demonstrates that catanionic surfactant vesicles are ideally suited to serve as the platform 
for the development of technology that will facilitate a mechanistic understanding of 















Figure 1.11. Proposed reaction mechanism of the inverting β-1,4-galactosyltransferase LgtE. 




Chapter 2: Expression, Purification, and Characterization of LgtE 
 
2.1  Introduction 
Glycans are complex, three-dimensional structures that unlike proteins are not 
encoded for or synthesized from a template. Rather glycosyltransferases catalyze the 
transfer of monosaccharides onto an acceptor substrate. Glycan structural diversity is 
influenced by cellular metabolism,7 developmental stage,4 cell type,7 and nutrient 
availability,43 and as such glycoconjugates are often isolated as heterogeneous glycan 
structures.57  
Low yields of coupling reactions and complications arising from effective control 
of regio- and stereoselectivity during glycan synthesis, in addition to the difficulty in 
isolating pure structures, results in a limited availability of homogenous glycoconjugates. 
The limited availability of ligands has significantly challenged investigations of protein-
glycan interactions at a molecular level.17 Development of large-scale production 
techniques for complex carbohydrates is of critical importance in the field of glycomics. 
These techniques would facilitate further investigations into glycan structure, function, 
and recognition. Additionally, the facile synthesis of oligosaccharides of known structure 
would have a significant impact in the pharmaceutical industry, since therapeutic 
glycoproteins are commonly employed in the treatment of chronic and infectious 
diseases. However, manufacturers continue to have difficulty producing drugs with a 
homogenous glycan profile, as required by the U.S. Food and Drug Administration 
(FDA).58 A recent report further highlighted the pressing need for a system that allows 
for the synthesis of homogenous glycans, with the revelation that three commercially 
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available glycoprotein drugs exhibit batch variation.59 Owing to the diverse role glycans 
play in the biological functions of glycoproteins, this revelation raises serious regulatory 
concerns. 
The in vitro utilization of purified bacterial glycosyltransferases is recognized as a 
potential method for the biosynthesis of complex oligosaccharides.15, 54 
Glycosyltransferases expressed in Gram-negative bacteria are an optimal choice as 
compared to their mammalian counterparts. The enzymes involved in LOS biosynthesis 
synthesize human glycoconjugates mimics10 but lack a N-terminal transmembrane 
domain.15 Therefore, bacterial enzymes are more soluble than their mammalian 
counterparts facilitating their expression and purification.15 Two previous studies provide 
evidence that N. meningitidis glycosyltransferases are amenable to the large-scale 
production of oligosaccharides.15, 54 In these in vitro studies, the β-1,4-
galactosyltransferase, LgtB, the α-1,4-galactosyltransferase, LgtC, and the β-N-
acetylglucosaminyltransferase, LgtA, were observed to modify a synthetic acceptor 
substrate and were not inhibited by nucleotide uridine-diphosphate (UDP), a reaction 
byproduct. 
The previous research performed with Neisseria glycosyltransferases lends 
credence to the development a one-pot multi-enzyme system for the in vitro synthesis of 
oligosaccharides.60 To fully synthesize the mimics of human glycans such as lacto-N-
neotetraose, Gal-β-1,4-N-GlcNAc-β-1,3-Gal-β-1,4-Glc, or the Pk blood group 
trisaccharide, Gal-α1,4-Gal-β-1,4-Glc, however, the enzyme responsible for the initial β-
Gal addition must be obtained. Previous research provided biochemical evidence that the 
enzyme encoded by the lgtE gene was responsible for this initial β-1,4-
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galactosyltransferase event in Neisseria LOS biosynthesis.2 Piekarowicz and Stein 
provide direct evidence of the enzyme’s in vitro activity and flexible acceptor substrate 
specificity on various LOS structures. Additionally, the study conducted by Piekarowicz 
and Stein contradicted the previous conclusion by Wakarchuk et al. that LgtE was unable 
to modify synthetic β-glycosyl acceptor substrates in vitro.61  
2.2 Specific Aims and Results 
 Based on these contradictory findings, the goals of this thesis were: 
1.  To establish the conditions for the stable expression and purification of LgtE, and 
2. To develop a high-throughput technique demonstrating the purified enzyme’s β-1,4-
galactosyltransferase activity. In the process of determining the appropriate conditions for 
expression, I also developed a novel method for the solubilization of membrane-
associated macromolecules. 
2.2.1 Optimization of LgtE Expression in E. coli 
The glycosyltransferases involved in the biosynthesis of LOS, including LgtE, are 
predicted to be noncovalently associated, via pairs of dibasic residues in the C-terminus, 
with the periplasmic membrane in vivo.15 This property precludes the complete solubility 
of the full-length recombinant proteins. Previously, it was reported that the majority of 
LgtE was present in the insoluble fraction of the cell extract and that there were 
precipitated proteins present both before and after purification.2 In an effort to increase 
protein solubility, the cell lysate was supplemented with the chaotropic agent, urea. 
Chaotropic agents disrupt inter- and intra-molecular noncovalent interactions, inducing 
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protein denaturation and facilitating solubilization. While the majority of the protein 
remained in the insoluble fraction under denaturing conditions, a significant amount was 
observed in the soluble fraction (Figure 2.1 lane 2 and Appendix A2). 
2.2.2 Purification of LgtE 
The soluble fraction was applied to Ni2+-NTA resin (Qiagen) according to the 
manufacturer’s instructions. Subsequently, the eluate was dialyzed to remove excess 
imidazole and reapplied onto the Ni2+-NTA column. Following this second round of 
purification, a single band of approximately 35 kDa was observed by SDS-PAGE 
analysis, indicating that purified protein was obtained (Figure 2.2 lane 1).  
      
Figure 2.1. 15% Tris-HCl SDS-PAGE of 8M urea solubilized LgtE. E. coli cells were grown 
to mid-log phase and LgtE expression was induced by the addition of 1 mM IPTG. Lane 1: 7 
µl Kaleidoscope prestained standards (Bio-Rad Laboratories, Hercules, CA.). Lane 2: Soluble 
fraction uninduced. Lane 3: Soluble fraction with 8M urea treatment.  Lane 4: Lysing buffer 
alone. Lane 5: Insoluble fraction with 8M urea treatment. LgtE is predicted to run at 
approximately 35 kDa2, and is indicated by the arrow. 
 







Despite the multiple rounds of purification, there remained a small amount of low 
molecular weight co-eluate, in fraction 4. At present, the identity of this band is 
unknown, however, it is likely that there was some proteolysis of the full length protein 
with the resultant polypeptide retaining the N-terminal hexahistadine tag. 
2.2.3 Demonstration of In Vitro Glycosyltransferase Activity on Whole Cell 
Gonococcus 
Following protein purification, the fractions containing purified protein were 
pooled and dialyzed against the dialysis buffer (Materials and Methods). Under these 
conditions there was no observed protein precipitation, indicating an improvement in the 
purification conditions as compared to previous work performed in our lab.2 The purified 
enzyme was stored at -20 oC.  
 
Figure 2.2. 15% Tris-HCl SDS-PAGE of purified LgtE. Following dialysis after the first Ni2+-
NTA column purification, the recovered protein sample was re-purified on new resin. (From 
right to left) Lane 1: 11 µl elution fraction 4; Lane 2: 11 µl elution fraction 3; Lane 3: 11 µl 
elution fraction 4; Lane 4: 7 µl Kaleidoscope prestained standards. The arrow indicates the 
band corresponding to the purified protein. 
 
  1    2    3                   4  
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To confirm that LgtE had re-folded properly and that β-1,4-galactosyltransferase 
activity is maintained, I developed an indirect enzyme-linked immunosorbent assay 
(ELISA) procedure to detect LgtE catalyzed LOS modification on whole cell 
gonococcus. Figure 2.3 illustrates the method by which product formation is detected. 2-
1-L8, a monoclonal antibody specific for LOS expressing a lactosyl α- chain structure,40 
is used as the capture antibody. The antibody will not bind the glucose terminal acceptor 
substrate (Figure 2.3A); however, following LgtE LOS modification, in which a 
galactosyl moiety is transferred to the terminal glucose residue, the whole cell 
gonococcus will now be retained by 2-1-L8 (Figure 2.3B). 
 
 
Figure 2.3. Schematic of the indirect ELISA experimental setup. A. Negative control: 
F62ΩEcoRI will not bind to the capture antibody, as it expresses a glucose terminal LOS 
structure. B. Positive control: F62Δ8-1 expresses the lactose terminal LOS structure that is the 
epitope recognized by the capture antibody. This structure is the product of LgtE LOS 
modification. 
 
A.                                             B. 
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LgtE was incubated in reaction buffer containing N. gonorrhoeae strain 
F62ΩEcoRI. Strain F62ΩEcoRI primarily expresses a LOS structure composed of a 
single glucose in the α-chain and a phosphate as the β-chain.43, 62 Incubation of whole cell 
F62ΩEcoRI with LgtE increased retention by the capture antibody, indicating that LgtE 
mediated the transfer of galactose to the acceptor substrate (Figure 2.4). 
2.2.4 Novel Purification Technique Using Surfactant Vesicles  
Our colleagues in the DeShong group have demonstrated that molecules 
associated with the membrane of whole cell bacteria will associate with SDBS-rich 
catanionic surfactant vesicles. I sought to take advantage of this observation to increase 
the solubility of LgtE in E. coli. LgtE is presumed to associate with the inner membrane 
of N. gonorrhoeae in vivo. I hypothesized that the protein would preferentially associate 
with catanionic vesicles. It appears in figure 2.5A lanes 6-8 that the band corresponding 
to the induced protein, LgtE, is associated with purified vesicles.  
 
Figure 2.4. Quantification of LgtE catalyzed modification of whole cell LOS by indirect 
ELISA. Whole cell F62ΩEcoRI serves as the negative control, and whole cell F62Δ8-1 serves 




Further, the vesicle extraction method was used to extract insoluble proteins from 
the cell pellet. The data presented in figure 2.5B lane 6 indicates that the vesicles 
selectively enrich for the induced protein, as there are less co-extracted proteins 
compared to the soluble fraction obtained under denaturing conditions. To account for 
potential misinterpretation based on variations in gel loading, the OD650 was monitored to 
ensure that the cell density under all conditions was consistent. Additionally, the pellet 
that was not solubilized by surfactant vesicles was re-suspended with the minimal amount 
of Triton-X 100 required to obtain a suspension in Laemmli buffer.  Further work is 
                             
Figure 2.5. A. Vesicle extraction of membrane associated molecules. Silver stain of 10-20% 
Tris-HCl SDS-Page analysis of fractions collected from Sepharose 2B size exclusion column. 
Lane 1: Kaleidoscope protein ladder; Lane 2: Uninduced supernatant; Lane 3: Induced 
supernatant; Lane 4: Lysing buffer alone; Lane 5: Fraction 1; Lane 6: Fraction 2; Lane 7: 
Fraction 3; Lane 8: Fraction 4; Lane 9: Fraction 5; Lane 10: Fraction 6. Arrow indicates that 
band that corresponds to the apparent molecular weight of LgtE B. Vesicle extraction of 
insoluble molecules from the cell pellet. Coomassie Blue stain of 15% Tris-HCl SDS-Page 
analysis. From left to right: Lane 1: Kaleidoscope protein ladder; Lane 2: Supernatant under 
non-denaturing conditions; Lane 3: Lysing buffer alone; Lane 4: Pellet under non-denaturing 
conditions; Lane 5: Lysing buffer alone; Lane 6: Pellet from non-denaturing conditions re-
solubilized with anionic surfactant vesicles. 
 
A.      1    2   3   4    5   6   7    8   9  10         B.     1       2   3   4   5   6 
37 
 
needed to determine if the extracted protein can be purified on a Ni2+-NTA column and if 
the protein is catalytically active following purification, but this preliminary data 
indicates that catanionic surfactant vesicles may be used to enrich for insoluble proteins.     
2.3 Discussion 
The exploitation of glycosyltransferases for the large-scale production of 
oligosaccharides is worthy of further investigation. A major technical difficulty hindering 
the development of a “one pot” system is the low solubility of glycosyltransferases. 
Despite lacking the transmembrane domains of their mammalian counterparts, numerous 
reports have demonstrated that bacterial enzymes are fairly insoluble, consistent with the 
observations made in this study.2, 15, 54, 61 While it is possible to truncate the enzyme, the 
C-terminus is predicted to contain the domain responsible for acceptor substrate 
binding.12 Therefore, removal of this flexible region may perturb the very same flexible 
substrate specificity that I hope to exploit for biosynthetic studies.15  
This work aimed to increase the solubility and stability of the recombinant 
enzyme. Using the above outlined techniques, including urea solubilization and vesicle 
extraction, a variety of recombinant bacterial glycosyltransferases may be purified to a 
working concentration, and subsequently utilized for oligosaccharide biosynthesis in 
vitro.  
2.4 Experimental 
2.4.1 Bacterial Strains, Plasmids, Oligonucleotides, and Culture Conditions.  
N. gonorrhoeae strain F62 wild-type was obtained from P. Fredrick Sparling, 
University of North Carolina, Chapel Hill. F62Δ8-1 has been previously characterized in 
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this laboratory.40, 63 E. coli strain BL21 (DE3) [fhuA2 [lon] ompT gal (λ DE3) [dcm] 
∆hsdS λ DE3 = λ sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5] was 
obtained from New England Biolabs (Ipswich, Mass.). Plasmid pET15b was obtained 
from Novagen (Madison Wis.). Cloning of lgtE into pET15b done by Dr. Piekarowicz 
and was previously described.2 
Neisseria strains were grown in standard gonococcal medium (designated GCP if 
broth and GCK if agar) (Difco Laboratories) plus growth supplements.64 The broth media 
is supplemented with 0.042% sodium bicarbonate for cultures grown under aerobic 
conditions, otherwise cultures were incubated at 37°C in a CO2 incubator. E. coli strains 
were grown on Luria Bertani (LB) agar or in LB broth.65 When antibiotic selection is 
necessary, ampicillin is used at a concentration of 50 µg/ml.  
2.4.2 Chemicals, Reagents, Enzymes.  
Restriction enzymes were purchased from New England Biolabs (Ipswich, 
Mass.). All chemicals used were reagent grade or better and were purchased from Sigma 
Chemical Co. (St. Louis Mo.) unless specified otherwise. 15% and 10-20% precast Tris-
HCl gels were obtained from Bio-Rad Laboratories (Richmond, Calif.).  
1x SDS-PAGE running buffer was made with 192 mM glycine, 25 mM Tris, and 
0.1% SDS in Elix water. 3x Laemmli buffer was prepared with 10% glycerol, 1 M Tris-
HCl pH 6.8, 2% SDS, 4% β-mercaptoethanol, and a pinch of bromophenol blue.66 
Coomassie Brilliant Blue stain was prepared by dissolving 0.25 grams Coomassie 
Brilliant Blue R-250 per 100 ml of 5:4:1 methanol: Elix water: acetic acid solution. 
Particulate matter was removed by vacuum filtration through a 0.22 μm bottle top filter 
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(Corning, Corning, NY). Coomassie Brilliant Blue destaining solution is the 5:4:1 
methanol: Elix water: acetic acid solution.  
Silver staining solutions were prepared as reported by Tsai et al.67 The gel was 
fixed in 10:1 ethanol: acetic acid solution. The sensitization solution was prepared by 
dissolving 0.83 grams periodic acid in 100 ml Elix water. Silver-ammonia staining 
solution was prepared by adding 180 mM ammonia drop wise to 0.75% silver nitrate with 
45 mM NaOH. Formaldehyde developer contains 200 mg/L citric acid and 0.1% 
formaldehyde.  
2.4.3 Transformation  
Plasmid pET15b-lgtE was transformed into E. coli strain BL21 (DE3), and a 
single colony was used to inoculate 25 ml of LB broth containing ampicillin. Cells were 
incubated with moderate shaking at 37°C until the optical density at 600 nm reached 0.6. 
5 ml of the starter culture was then used to inoculate 250 ml of LB broth. Again, the cells 
were incubated with moderate shaking at 37°C until the optical density at 600 nm 
reached 0.6.  
2.4.4 Induction and Expression of LgtE 
Protein expression was induced by the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG) to the culture. IPTG was added to a final concentration of 1 
mM, and incubations were continued for 3 hours at 37°C. The cells were collected by 
centrifugation at 4°C and re-suspended. For purification under non-denaturing conditions, 
the cell pellet was re-suspended in a minimal volume of lysing buffer containing 50 mM 
NaH2PO4, 300 mM NaCl, and 10 mM imidazole pH 8.0. Additionally for purification 
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under non-denaturing conditions, lysozyme to a final concentration of 100 µg/ml, 100 
µM phenylmethylsulfonyl fluoride (PMSF), and 0.1% Triton X-100 were added to the re-
suspended pellet. The mixture was incubated on ice for 60 minutes. For purification 
under denaturing conditions, the cell pellet was re-suspended in a minimal volume of 
lysis buffer containing 100 mM NaH2PO4, 10 mM Tris, and 8 M urea pH 8.0.  
Cells were lysed by three cycles of freeze thawing at -80°C. To ensure complete 
lysis, the suspension was transferred to a glass tube and sonicated for a minimum of five 
pulses at 10 seconds each on ice. The cell extract was clarified by centrifugation for 30 
minutes at 15,000 rpm at 4°C in a Sorvall SS34 rotor, and the supernatant containing the 
soluble fraction was separated from the insoluble pellet. Both the soluble fraction and the 
insoluble pellet were stored at 4°C, until further analysis or purification. 
2.4.5 Protein Purification 
 All purification steps were performed at 4°C. The soluble fraction was then 
incubated with Ni2+-NTA resin (Qiagen), rocking, for a minimum of three hours. The 
protein-resin mixture was subsequently packed, according to manufacture instructions, in 
a column. The flow through was collected and reapplied to the column two times to 
ensure saturation of the Ni2+-NTA resin. The resin was then washed with 5 column 
volumes of denaturing wash buffer containing 100 mM NaH2PO4, 10 mM Tris, and 8M 
urea, 20 mM imidazole pH 8.0. The protein was eluted following application of the 
elution buffer containing 100 mM NaH2PO4, 10 mM Tris, and 8M urea, and 250 mM 
imidazole pH 8.0. All buffers were made fresh and equilibrated to a temperature of 4 °C.  
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 Following the first round of purification the elute fractions that contained protein 
were determined by SDS-PAGE analysis. These fractions were dialyzed against the 
denaturing lysis buffer pH 8.0, overnight at 4 °C. The protein mixture was then applied to 
3 ml of fresh Ni2+-NTA resin pre-packed in a clean column. Again, the collection volume 
was reapplied twice to ensure saturation. The column was washed and the bound protein 
was eluted, as previously described. The presence of purified protein was determined by 
SDS-PAGE. 
 The purified protein was refolded by overnight dialysis at 4°C against buffers 
containing a linear reduction in urea concentration (8M, 6M, 4M, 2M, 1M, 0.5M, and 
0M). Additionally, dialysis buffers contained 20 mM HEPES pH 7.5, 10 mM β-
mercaptoethanol, 0.5 mM PMSF, 50 mM glycine, 5 mM EDTA, and 20% glycerol. The 
enzyme was then stored at -20 °C. 
2.4.6 SDS-PAGE Analysis  
5 µl of the cell pellet solubilized with Triton X- 100 was added to 3x Laemmli 
lysing buffer. 5 µl (unless otherwise noted) of column fractions or the soluble fractions 
were added to 3x Laemmli buffer. The samples were run on a 10-20% Criterion™ 
Precast Tris-HCl gel in 1x Tris-glycine running buffer at 100 volts for approximately 2.5 
hours.  
Those gels analyzing whole cell lysates were stained with Coomassie Brilliant 
Blue. Staining followed the method outlined by Sambrook et al.68 whereby following 
SDS-PAGE analysis the gel is incubated in Coomassie staining solution for 16 hours. The 
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next day, the stain was removed and protein bands were visualized by washing out excess 
Coomassie dye with de-staining solution.  
To detect lower protein concentrations such as in fractions collected off the Ni2+-
NTA column, gels were stained with silver salts.67, 68 The gel was fixed overnight in a 
solution of 40% ethanol- 5% acetic acid and then oxidized in 0.83% periodic acid for 5 
minutes. The gel was washed for 2 hours in multiple changes of H2O every 20 minutes, 
stained for 5 minutes in silver staining solution (22.5 mM NaOH, 0.42% NH4OH, 47 mM 
AgNO3), and rewashed for 2 hours in multiple changes of H2O every 20 minutes. The gel 
was developed (100 ml of 0.005% citric acid-0.007% formaldehyde) until bands became 
visible. A digital image of the gel was then obtained on a flatbed scanner. 
2.4.7 Construction of F62ΩEcoRI 
 N. gonorrhoeae strain F62ΩEcoRI was originally constructed by Dr. Derek 
Braun.44 Following the defined protocol, N. gonorrhoeae strain F62 was transformed 
with the plasmid pLgtDEΩEcoRI. pLgtDEΩEcoRI has a spectinomycin-resistance 
(specR) Omega interposon cassette (Ω), flanked by rho-independent transcriptional 
terminators, inserted downstream of the putative promoter initiating lgtE transcription.  
 To verify that the Ω cassette had properly inserted into the EcoRI site 1% agarose 
gels were prepared in TBE buffer with 10 µl ethidium bromide (10 mg/ml). Agarose gel 
electrophoresis was performed at constant voltage (100 V) until the loading dye front had 
reached the bottom of the gel. Gels were visualized using a Gel Doc XR ultraviolet 
transilluminator (Biorad) and gel images were processed using Quantity One 1-D 
analytical software version 4.6.1 (Biorad).  
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The resulting LOS phenotype of the recombinant F62ΩEcoRI strain is equivalent 
to the inactive LgtE, or ΔlgtE, LOS chemotype, as confirmed by SDS-PAGE analysis. 
2.4.8 Galactosyltransferase Assay 
 Reactions were carried out in a total volume of 50 μL. The reaction buffer 
contained 20 mM HEPES pH 7.5, 1 mM MnCl2, 5 x 10
6 whole cells, 1 μg purified LgtE, 
and 1 mM UDP-α-D-galactose (Santa Cruz Biotechnology). The reaction was carried out 
for a minimum of 3 hours at 30 °C. Whole cell bacteria were killed by gentamicin sulfate 
(100 μg/ml) treatment for 3 hours at 37 °C, prior to the reaction with LgtE. The controls 
contained all the components of the reaction buffer minus UDP-galactose. 
2.4.9 ELISA 
 Monoclonal antibody 2-1-L840 was added undiluted to the wells of a 96 well 
microtiter plate (Corning, Corning, NY). The wells were then blocked with 0.1% 
blocking reagent (Roche Applied Science, Indianapolis, IN). Wells were washed with 
0.1% PBS-Tween wash buffer pH 7.4. The control and reaction mixtures were incubated 
in the wells for a minimum of one hour, followed by PBS-Tween wash. Polyclonal goat 
anti-gonococcus antibody was then incubated in the wells. Following a wash step, donkey 
anti-goat IgG conjugated to horseradish peroxidase (Jackson ImmunoResearch 
Laboratories, West Grove, PA) was added to the wells. After a final wash step, 3,3′,5,5′-
tetramethylbenzidine (Sigma Aldrich, St. Louis, MO) liquid substrate was added to the 
wells and the plate was protected from light. The OD at 645 nm was measured with 
SpectraMax 190 Absorbance Plate Reader (Molecular Devices, Sunnyvale, CA), and data 
were acquired with SoftMax Pro Software (Molecular Devices, Sunnyvale, CA). 
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2.4.10 Surfactant Vesicle Solubilization 
 Sodium dodecylbenzenesulfonate (SDBS) was purchased from TCI America and 
was utilized without further purification. Cetyltrimethylammonium tosylate (CTAT) was 
purchased from Sigma and was recrystallized from ethanol-acetone to give a white 
powder. The purified solid was stored at room temperature in a desiccator containing 
Drierite. The cell pellet, with a wet mass of approximately 1.5 grams, was re-solubilized 
in 30 ml of Elix water and 21 mg of SDBS. The pellet-surfactant mixture was gently 
stirred, at 4 °C, for 16 hours. 9 mg of CTAT was then added to the mixture, for a total 
surfactant concentration of 1 wt %, and stirring continued for a minimum of 3 hours. The 
cell pellet was cleared by centrifugation, 2 ml of the pellet-surfactant mixture loaded on a 
Sephadex G-25M column, length 5.5 cm, diameter 5.5 cm, (GE Healthcare Biosciences, 
Pittsburg, PA) and centrifuged at 1000 rpm for 25 min in a Sorvall RC-3B centrifuge 
with an H-1000B swinging bucket rotor (Thermo Fisher Scientific). 
 Vesicles were then purified by size exclusion chromatography. The cleared cell 
lysate was loaded on to a Sepharose 2B column, length 5.5 cm and diameter 1.5 cm, (GE 
Healthcare Biosciences, Pittsburg, PA). The void volume of the Sepharose 2B column 
was determined by noting blue dextran elution in fractions 2-4. Vesicle solution (1 ml) 
was added to the column and collected as the first fraction. Fifteen 1.0 ml fractions were 
collected. The vesicles were observed to elute in fraction 2-4, in accordance with 




2.4.11  List of Bacterial Strains and Plasmids Used 
Strain or plasmid Description Source or 
Reference 






~4000-bp amplicon corresponding to bp 1650 
to 2364 of the lgtABCDE region, cloned into 
the EcoRI and BamHI sites of pGEM7Zf(-). 
The Ω interposon is ligated into an engineered 
EcoRI site between lgtD and lgtE. 
D.C. Braun  
F62ΩEcoRI N. gonorrhoeae F62 strain transformed with 
pDCB19ΩEcoRI. The LOS phenotype is 
equivalent to ΔlgtE. 
 
This work. 
F62Δ8-1 N. gonorrhoeae F62 strain with a 239-bp ApoI 
deletion in lgtA; this strain produces L8+ LOS 
and is equivalent to ΔlgtA LOS phenotype.  
W. Song 
E. coli BL21(DE3) F– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 




pET15b-lgtE A fragment of F62 chromosomal DNA 
encoding the lgtE gene was cleaved with NdeI 
and BamHI and ligated into the expression 
vector pET15b that had been cleaved with the 
same enzymes. The ligation mixture was used 
to transform E. coli BL21(DE3). 











Chapter 3: Demonstration of Oligosaccharide Biosynthesis by N. 
gonorrhoeae LgtE on Functionalized Catanionic Surfactant Vesicles 
 
3.1 Introduction 
Glycan binding proteins (GBPs) are found in both vertebrates and non-vertebrates 
and encompass families of lectins and anti-carbohydrate antibodies.69 It is through the 
interactions with the cognate GBPs that carbohydrates mediate various cellular functions 
including adhesion, cellular signaling, tumor metastasis, inflammation, and immune 
responses.3 The ubiquity of glycan-protein interactions in biological processes underlies 
the need to develop a platform that would allow for the high-throughput analysis of these 
interactions at the molecular level.  
Since 2002, when the first glycomic array was reported, numerous groups have 
developed a variety of techniques to conjugate glycans to a scaffold for high-throughput 
analysis.19 A major hindrance to the commercialization of any one glycomic array 
platform is the critical importance of spatial arrangement and density of the presented 
glycans. The need to control both the density and the display of glycans is necessitated by 
the multidentate binding characteristics of GBPs (Figure 3.1A).  GBPs have low binding 
affinity for individual ligands, with dissociation constants in the millimolar to micromolar 
range, but can establish specificity and high affinity through multivalent binding.70 
Compounding the difficulty in obtaining reproducible data from different glycomic 
platforms, is the observation that not only can suboptimal ligand density affect GBP 
interactions, but also the glycan conjugated linker can have a significant impact on GBP 
binding.17 Gildersleeve and coworkers have demonstrated that variations in the density 
and the scaffold utilized for glycan presentation is responsible for variations in the glycan 
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binding profile of the same GBP.24 There is evidence that optimal presentation of glycans 
is specific for each glycan binding protein, and the correct presentation is difficult to 
predict. Therefore, the appropriate scaffold, ligand density, and the orientation must be 
determined empirically for each glycan binding protein. In an effort to develop a platform 
in which glycan density can be easily varied in a controlled fashion, our collaborators in 
the DeShong laboratory have focused on functionalized catanionic surfactant vesicles.  
As described in detail above, catanionic vesicles were initially characterized by 
Kaler and coworkers in 1989.31 These colloidal aggregates form spontaneously upon 
mixing the cationic surfactant CTAT with a molar excess of the anionic surfactant SDBS. 
The vesicles form a unilamellar bilayer and, with an excess of SDBS, have an overall 
surface charge of approximately -55 millivolts (mV), comparable to the surface charge of 
a Gram-negative bacterium.37  
Our collaborators have demonstrated that catanionic vesicles can be 
functionalized with glycoconjugates and that the resulting vesicles can be utilized for the 
study of lectin binding. The glycoconjugates carrying a hydrophobic C12 tail 
spontaneously insert into the vesicle leaflet through hydrophobic interactions and are 
bioavailable, as observed in solution with lectin induced agglutination (Figure 3.1B).32 
Thomas and coworkers demonstrated that the concentration of the incorporated 
glycoconjugates could be controlled by simply adding more or less to the preparation, 
and that the spatial distribution of the glycans could be determined by lectin mediated 
aggregation kinetics studies.32 We have observed that LOS extracted from N. 
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gonorrhoeae spontaneously incorporates into the vesicle bilayer through hydrophobic 
interactions via the lipid A moiety.37 
Due to the low-cost of the individual surfactants, the facile preparation and long-
term stability of the vesicles, and based on previous reports suggesting the ability to 
immobilize functionalized catanionic vesicles on a variety of surfaces, glycan-
functionalized catanionic surfactant vesicles may be an ideal scaffold for the 
development of a glycomic array.  
 
Figure 3.1. Glycan density and spatial arrangement have a significant influence carbohydrate 
binding protein affinity. A. Low glycan density attenuates GBP affinity for the cognate ligand 
by reducing the probability of formation of multivalent binding complexes B.  Catanionic 
vesicles can be functionalized with glycoconjugates, such that the density of the surface 












3.2 Specific Aims and Results 
 The primary aim of this research is to demonstrate the utility of catanionic 
vesicles as a platform for the in vitro synthesis of oligosaccharide structures. Enzymatic 
modification of functionalized SDBS-rich vesicles is demonstrated by a variety of 
analytical techniques. Herein, evidence is provided of the bioavailability of the 
functionalized moiety, and the results are proof-of-principle that recombinant N. 
gonorrhoeae glycosyltransferases can be employed in an enzymatic toolkit for the in 
vitro synthesis of glycans on this novel platform. 
3.2.1 Demonstration of LgtE Glycosyltransferase Activity on Whole Cells and 
on Functionalized Surfactant Vesicles 
 Piekarowicz and Stein previously reported that LgtE catalyzes the transfer of 
multiple galactose residues to an LOS substrate, when the enzyme is present in excess, 
and this transformation could be visualized as multiple bands by SDS-PAGE.2 This 
observation indicated that LgtE had relaxed acceptor substrate specificity and could 
function as a poly-galactosyltransferase. 
 To determine the galactosyltransferase activity of the enzyme on whole cell LOS 
and on LOS functionalized vesicles, LgtE was incubated in reaction buffer containing 
donor substrate and either LOS functionalized vesicles or whole cells as the acceptor 
substrate. The data presented in figure 3.2 indicate that LgtE transferase activity is 
maintained on whole cell N. gonorrhoeae strain F62ΩEcoRI LOS, the natural acceptor 
for the enzyme, with the appearance of multiple higher molecular weight bands (lanes 1 
versus lane 2). Under the experimental conditions employed, each band corresponds to a 
LOS structure of a molecular weight that is one galactose larger than the band below it.  
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Following incubation of catanionic vesicles functionalized with ΔlgtE LOS 
(Figure 3.2, lane 3), LOS isolated from these vesicles produced multiple higher molecular 
weight bands, indicating that LgtE is able to modify LOS functionalized surfactant 
vesicles (Figure 3.2, lane 4). Taken together the data in figure 3.2 indicate that the 
purified galactosyltransferase is active in vitro on acceptor substrates presented both in a 
whole cell and in a catanionic surfactant vesicle background.   
To quantitatively assess LgtE transferase activity on functionalized surfactant 
vesicles, the amount of product observed in figure 3.2 was determined using image 
analysis software.1 Figure 3.3 is a profile plot of the relative pixel density in each band 
observed in lane 4 of figure 3.2. Integration of the individual peaks quantifies the degree 
of product formation. Gel analysis indicates that LgtE converted approximately 54% of 
the glucose terminal LOS functionalized vesicles into either mono- or di-galactosyl 
terminal structures (Table 3.1). Based on the apparent higher density of the Gal-β1,4-Gal-
β1,4-Glc LOS band as compared to the Gal-β1,4-Glc LOS band, it appears that LgtE 
preferentially catalyzes the addition of a galactose molecule onto galactose terminal LOS 
structure. This observation may be explained by the fact that under the conditions of this 
 
       
Figure 3.2. SDS-PAGE of whole cell LOS and LOS functionalized vesicles following LgtE 
modification. Lane 1: 1:10 dilution of F62ΩEcoRI whole cell LOS. Lane 2: F62ΩEcoRI 
whole cell LOS following LgtE reaction. Lane 3: ΔlgtE LOS vesicles. Lane 4: ΔlgtE LOS 
vesicles following reaction with LgtE. Lane 5: Δ8-1 LOS vesicles. 
 
    1     2   3        4   5 
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assay, where UDP-galactose is present at saturating concentrations and LOS is limiting, 
diffusion dictates the frequency of collisions between LOS molecules in the vesicles and 
the enzyme, and therefore random interactions with unmodified LOS are less probable 
than random interactions with previously modified LOS.  
3.2.2 Differential Lectin Binding Demonstrates the Diversity of 
Glycoconjugates on Bacterial Cells 
The data presented above indicate that LgtE mediates the transfer of a galactosyl 
group to both glucose and galactose terminal LOS presented on a whole cell or catanionic 
 
Figure 3.3. Gel analysis of LOS functionalized catanionic surfactant vesicles following 
reaction with LgtE. Peak 1 corresponds to the highest molecular weight band, presumed to be 
the Gal-β1,4-Gal-β1,4-Glc LOS structure. Peak 2 corresponds to the middle molecular weight 
band, presumed to have an LOS structure of Gal-β1,4-Glc. Peak 3 corresponds to the 
unmodified Glucose terminal LOS structure. Peaks were obtained using ImageJ software.1 
 
    1    2    3 
 Area 
(pixels2) 
Percent Relative Density 
Glc LOS 26311.4 46.1 1 
Gal-β1,4-Glc LOS 13738.6 24.1 0.52 
Gal-β1,4-Gal-β1,4-
Glc LOS 
16974.04 29.8 0.64 
 
Table 3.1. Quantification of gel analysis on LOS functionalized vesicles following incubation 
with LgtE. The area of each band is expressed in square pixels. The relative density is 
determined by dividing the percent of each product band by the percent of the unreacted 




vesicle. SDS-PAGE analysis, however, does not provide specific information on the 
composition of the product LOS structure. As an alternative approach to demonstrating 
LgtE activity on whole cells and vesicles, the differential binding of labeled lectins was 
assayed. 
I developed a quantitative assay demonstrating lectin binding to whole cell 
gonococcus and to functionalized surfactant vesicles. Flow cytometry was determined to 
be an ideal method that could be adapted for this purpose. Initially, I investigated LgtE 
modification of whole cell LOS. The acceptor substrate, glucose terminal LOS expressed 
on F62ΩEcoRI, was labeled with Concavalin A (ConA), as depicted in figure 3.4A. 
ConA specifically recognizes α-D-mannopyranosyl, β-D-glucopyranosyl, and β-D-
fructofuranosyl moieties. Quantification of product formation, galactose terminal LOS, 
 
Figure 3.4. Schematic of differential lectin binding as assessed by flow cytometry. The 
unmodified acceptor substrate is a glycoconjugate expressing a terminal glucosyl moiety (A). 
This structure is preferentially bound by the lectin ConA. Following LgtE mediated galactose 
addition, the glycoconjugate no longer binds ConA. Rather, the galactosyl structure now 
preferentially binds PNA (B). This figure is meant to depict ligand binding in either a whole 













was assessed with labeled peanut agglutinin (PNA), a lectin specific for terminal β-
galactosyl residues (Figure 3.4B).  
Incubating LgtE with whole cells decreases the binding of ConA by 
approximately 1.5 fold, as is depicted in the comparison of figures 3.5A and 3.5B and is 
further quantified in figure 3.5E. In figure 3.5F it is also apparent that incubating the 
whole cells with LgtE decreases the forward-scattered light, which is proportional to size, 
of the detected events. This decrease in size can be explained by decreased agglutination 
of the whole cells by ConA following LgtE modification. 
Unexpectedly, N. gonorrhoeae strain F62ΩEcoRI bound a significant 
concentration of labeled PNA despite numerous washing steps. Pre-absorbing the whole 
cells with unlabeled PNA reduces the background binding, and it is apparent in figures 
3.5D and 3.5E that LgtE transferase activity increases the mean fluorescence of the 
events by approximately twofold (quantified in Figure 3.5E). Further, in figure 3.5F it is 
evident that the average size of the events increases following LgtE modification. Taken 
together the data indicate that LgtE maintains transferase activity in vitro on F62ΩEcoRI 
LOS, and that the activity can be assessed with labeled lectins by flow cytometry. 
Additionally, the data demonstrate that there are numerous glycosylated molecules other 
than LOS on the surface of the gonococcus to which PNA can bind.71, 72 The high 
background of glucosly-terminated glycans on the cell surface precludes the use of this 
assay for quantification purposes, and emphasizes the necessity in the field of glycomics 






    
   
  
Figure 3.5. LgtE mediates the transfer of a galactosyl group, in vitro, to whole cell 
F62ΩEcoRI. A. F62ΩEcoRI with ConA (positive control) B. F62ΩEcoRI with ConA 
following incubation with 1 µM LgtE. C. F62ΩEcoRI with PNA (negative control). D. 
F62ΩEcoRI with PNA following incubation with LgtE. E. Quantification of mean 
fluorescence depicted in panels a-d, respectively. F. Quantification of the average FSC-A for 
each condition depicted in panels a-d. Forward-scattered light (FSC-A) is proportional to the 
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3.2.3 LgtE Transferase Activity is Maintained on LOS Functionalized Vesicles 
The transferase activity of LgtE on functionalized surfactant vesicles was also 
analyzed. Initially, LgtE activity on ΔlgtE LOS functionalized catanionic vesicles was 




Figure 3.6. LgtE mediates the transfer of a galactosyl moiety to ΔlgtE LOS functionalized 
vesicles. A. ConA incubated with ΔlgtE LOS functionalized vesicles. B. ConA incubated with 
ΔlgtE LOS functionalized vesicles following reaction with LgtE. C. PNA incubated with 
ΔlgtE LOS functionalized vesicles. D. PNA incubated with ΔlgtE LOS functionalized vesicles 
following reaction with LgtE. E. Quantification of the mean fluorescence for all events 
depicted in panels a-d, respectively. 
 
A.      B. 




and 3.6B, LgtE mediated a twofold reduction in ConA binding to ΔlgtE LOS 
functionalized vesicles. Additionally, PNA binding was observed to increase by 
approximately tenfold following incubation of the vesicles with LgtE (Figures 3.6C and 
3.6D). The data quantified in figure 3.6E indicate that LgtE mediates the transfer of a 
galactosyl group to LOS functionalized catanionic surfactant vesicles.           
3.2.4 LgtE is Active on a Synthetic Substrate Incorporated into Surfactant 
Vesicles  
An aim of this study is to exploit the relaxed substrate specificity of LgtE to 
create glycans of defined structure and composition, employing acceptor substrates not 
necessarily derived from Neisseria LOS. To investigate the feasibility of exploiting LgtE 
for the modification of a diverse array of glucose terminal structures, I sought to 
demonstrate the activity of LgtE on C12-glucose functionalized surfactant vesicles (Figure 
3.7). In this experiment, it is hypothesized that transfer of a galactosyl residue to the 
glucopyranosyl-functionalized catanionic vesicle would result in a decrease in the ability 
of ConA to bind to the vesicle and a corresponding increase in the binding of PNA to the 
vesicle. 
 




As depicted in figures 3.8A and 3.8B and quantified in figure 3.8E, ConA binding 
was reduced twofold following reaction with LgtE. Figure 3.8E also indicates an 
approximately tenfold increase in PNA binding (depicted in Figures 3.8C and 3.8D). 
  
   
 
Figure 3.8. LgtE mediates the transfer of a galactosyl moiety to C12-Glucose functionalized 
vesicles. A. ConA incubated with C12-Glucose functionalized vesicles. B. ConA incubated 
with C12-Glucose functionalized vesicles following reaction with LgtE. C. PNA incubated 
with C12-Glucose functionalized vesicles. D. PNA incubated with C12-Glucose functionalized 
vesicles following reaction with LgtE. E. Quantification of the mean fluorescence for all 
events depicted in panels a-d, respectively. 
A.               B. 




Taken together, the data presented in figures 3.6 and 3.8 indicate that LgtE performs 
galactosyltransferase reactions, in vitro, on functionalized surfactant vesicles, 
independent of glycan origin.                        
3.2.5 Vesicle Integrity is Maintained Following Enzymatic Synthesis 
 The lectin binding data presented above indicate that LgtE glycosyltransferase 
activity is maintained on LOS incorporated in SDBS-rich catanionic surfactant vesicles. 
To confirm that enzymatic synthesis did not disrupt the integrity of the vesicles, the 
reaction buffer containing vesicles was applied to a Sepharose 2B column. Previous 
studies have reported that intact vesicles can be separated from free surfactant molecules 
and free glycans on a similar size exclusion matrix.32 Functionalized vesicles elute in the 
void volume, whereas free glycans and free LOS are retarded due to their small size and 
shape, thus eluting in later fractions.32 1 ml Fractions were collected, and the LOS species 
in fractions 2-4 were visualized by SDS-PAGE. Figure 3.9 (lanes 2-4) indicates that the 
vesicles are present in the void volume, with the majority in fraction 3 (lane 3). 
Additionally, a higher molecular weight band is present in the lane containing the 
reaction product that is not present in the negative control (lane 3 vs lane 1 Figure 3.9). 
The data in figure 3.9 indicate that the vesicles are intact following enzymatic synthesis 
 
Figure 3.9. Vesicles are intact following enzymatic synthesis. 16.5% Tris-Tricine gel. Lane 1: 
ΔlgtE vesicles (negative control). Lanes 2-4 are ΔlgtE vesicles following reaction with LgtE. 
Lane 2: Fraction 2. Lane 3: Fraction 3. Lane 4: Fraction 4. Lane 5: ΔlgtA vesicles (positive 
control). 
 
 1            2           3          4             5 
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and further confirm that LgtE glycosyltransferase activity is maintained on functionalized 
catanionic vesicles. 
3.3 Discussion  
Numerous studies have demonstrated the utility of catanionic surfactant vesicles 
for both in vitro investigations of glycan presentation.32, 37, 38 Our collaborators previously 
demonstrated that catanionic surfactant vesicles are particularly well suited for 
investigating protein: carbohydrate interactions because of the ease at which glycan 
density can be varied.32 The investigation of diverse glycan structures in this context is 
limited, however, by the requirement that a glycan must be conjugated to a hydrophobic 
moiety for incorporation into the vesicle bilayer.  
One possible method for broadening the scope of presented glycans is employing 
glycosyltransferases to synthesize oligosaccharides on the surface of vesicles. The work 
presented here indicates that N. gonorrhoeae β-1,4-galactosyltransferase LgtE 
biosynthesizes diverse glycans incorporated into catanionic surfactant vesicles. 
Significantly, it is observed from the data in figure 3.5 and 3.6 that LgtE mediates the 
transfer of a galactosyl group not only to glycans of neisseral origin, but also, as shown in 
figure 3.8, catalyzes the transfer of a galactosyl moiety to a synthetic glucose terminal 
substrate. Taken together, the data indicate the potential of bacterial glycosyltransferases 
for the chemo-enzymatic synthesis of diverse oligosaccharide structures. Recombinant 
glycosyltransferases, therefore, have enormous potential for use in biomedical 
engineering. For example, by modifying glycans found on the surface of human 
erythrocytes, one could make it possible for an individual with type A blood (α-1,3-
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GalNAc) to receive a transfusion of type B (α-1,3-Gal) donor blood, simply by 
incubating the cells with a specific recombinant glycosyltransferase.  
The data presented in figures 3.5, 3.6, and 3.8 also demonstrate that glycan 
binding protein recognition of incorporated glycans is maintained, and that these 
interactions can be investigated by a variety of analytical techniques, including FACS 
analysis. Flow cytometry is currently used in a number of laboratories for a variety of 
analyses including measuring a patient’s T-cell count or determining a patient’s antibody 
panel. The techniques developed in this dissertation facilitate the development of a new 
vesicle based platform in which a patient’s serum can be analyzed by standard flow 
cytometry techniques for the presence of antibodies against diverse carbohydrate 
antigens.  
Taken together, the data presented in this chapter provides a proof-of-concept that 
recombinant glycosyltransferases synthesize oligosaccharides, in vitro, on functionalized 
catanionic surfactant vesicles. Further, the data indicate that catanionic vesicles may be 
utilized as a platform for the investigation of protein-glycan interactions, and should be 
considered for development of glycomic array technologies.  
3.4 Experimental 
3.4.1 Chemicals, Reagents, Lectins, and Antibodies 
 All chemicals were reagent grade or better from Sigma Aldrich Co. (St. Louis, 
Mo.) unless specified otherwise. Cetyltrimethylammonium tosylate, sodium 
dodecylbenzemesulfonate, n-dodecyl β-D-glucopyranoside (C12-glucose), and proteinase 
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K were obtained from Sigma Aldrich Co. (St. Louis, Mo.). Tris-Tricine gels (16.5%) and 
running buffer were obtained from Bio-Rad Laboratories (Richmond, CA). 
 MAb 2-1-L8 was graciously provided by Wendell Zollinger (Walter Reed Army 
Institute of Research, Washington, DC). Alexa Fluor® goat anti-mouse IgG (H+L), 
Concavalin A Alexa Fluor® 488 conjugate (Molecular Probes®), and peanut agglutinin 
Alexa Fluor® 647 (Molecular Probes®) were purchased from Invitrogen Corp. 
(Carlsbad, CA). 
3.4.2  Preparation of Vesicles 
 Functionalized catanionic vesicles were prepared by members of the DeShong 
group. Sodium dodecylbenzenesulfonate (SDBS) was purchased from TCI America and 
was used without further purification. Cetyltrimethylammonium tosylate (CTAT) was 
purchased from Sigma and was recrystallized from ethanol-acetone to give a white 
powder. The purified solid was stored at room temperature in a desiccator containing 
Drierite.  
 Catanionic vesicles were prepared from SBDS and CTAT, with molar excess of 
SDBS. Anionic vesicles were prepared with 1 wt% of total surfactant by combining 70.0 
mg (200 µmol) of SDBS and 30.0 mg (65.8 µmol) of CTAT. Millipore water 18 Ω (9.90 
ml) was added to the mixture of surfactants, and the resulting solution was stirred for 24 
hours. Catanionic vesicles formed within 1 hour of mixing, based on the turbidity of the 




 Vesicles were purified by size exclusion chromatography. A column (5.5 cm 
height, 1.5 cm diameter) was packed with Sephadex G-100 (Sigma). Vesicle solution (1 
ml) was added to the column and collected as the first fraction. This was followed by the 
addition of 1 ml aliquots of water. Each 1 ml aliquot was collected in a separate vial. A 
total of 14 fractions were collected and the vesicles were observed in fractions 3 and 4. 
The presence of vesicles in fractions 3 and 4 was confirmed by dynamic light scattering 
(DLS). DLS measurements were performed by Dr. Neeraja Dashaputre in the DeShong 
lab. Based on a phenol-sulfuric acid based colorimetric assay these vesicle-containing 
fractions were observed to contain carbohydrate incorporated in them.37 Hence these two 
fractions were combined and used experimentally.  
 All glycan-functionalized catanionic vesicles were prepared and characterized by 
Dr. Neeraja Dashaputre. The results from these studies are reported here to provide 
complete experimental information regarding these materials. Glucose functionalized 
vesicles were prepared by combing 0.1 mole fraction of glycoconjugate with SDBS 
(mole fraction 70%) and CTAT (mole fraction 30%) in 9.9 ml of water. The solution was 
stirred for 24 hours.  
 LOS functionalized vesicles were prepared by combining 1.00 mg purified 
lyophilized LOS in 10 ml preformed 1% SDBS rich vesicle solution. The resulting 
vesicle preparation was purified as described above. 
3.4.3 LOS Purification for Functionalized Vesicles 
 LOS was purified from broth-grown cells with acetone-powdered organisms by 
the hot phenol-water method.73,32 LOS was extracted with hot phenol-water and 
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concentrated by lyophilization. Extractions were continued until the purified LOS gave a 
minimal absorbance when measured at 200 nm, ensuring minimal nucleic acid 
contamination.  
3.4.4 LOS SDS-PAGE Analysis 
 Whole cell gonococcal LOS was prepared from plated cultures as described by 
Hitchcock and Brown74 and diluted 1:25 in 1x Laemmli buffer. The suspension was 
heated to 65 °C for a minimum of 10 minutes. Reactions and vesicles were diluted and 
heated in the same manner. 20 µl of each sample were loaded onto a 16.5% Criterion™ 
Tris- Tricine Precast gel (Bio-Rad Laboratories Inc.). The gel was run at a constant 
current of 3 milliamphere (mA), on ice, for approximately 8 hours, or until the dye front 
reached the bottom of the gel.  
After electrophoresis, the gel was fixed overnight in a solution of 40% ethanol- 
5% acetic acid and then oxidized in 0.83% periodic acid for 5 minutes. The gel was 
washed for 2 hours in multiple changes of H2O every 20 minutes, stained for 5 minutes in 
silver staining solution (22.5 mM NaOH, 0.42% NH4OH, 47 mM AgNO3), and rewashed 
for 2 hours in multiple changes of H2O every 20 minutes. The gel was developed (100 ml 
of 0.005% citric acid-0.007% formaldehyde) until bands became visible.  
 A digital image of the gel was obtained on a flatbed scanner. Subsequently, the 
gel was analyzed with ImageJ software (Rosband W. U.S. National Institutes of Health, 
Bethesda, MD. http://imagej.nih.gov/ij/).   
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3.4.5 Flow Cytometry Analysis on Whole Cell Gonococcus 
 Pilin and Opa dual negative colonies of F62Δ8-1 and F62ΩEcoRI strains were 
selected and passaged. Bacterial cells were suspended in 20 mM HEPES pH 7.5 to an 
OD650 of 0.6. The cells were pelleted and fixed by re-suspension in 4% paraformaldehyde 
(PFA). Fixation proceeded for 10 minutes at room temperature with moderate shaking, 
and subsequently washed three times with 20 mM HEPES pH 7.5. Bacterial cells were 
fixed again for 10 minutes, and then washed five times with 20 mM HEPES pH 7.5. 
Fixed bacteria were stored in HEPES buffer at 4 °C.  
 8x105 bacteria were incubated with ConA Alexa Fluor® 488 conjugate in buffer 
(20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM CaCl2, 1 mM MnCl2, and 1 mM MgCl2) 
or with PNA Alexa Fluor® 647 conjugate in buffer (20 mM HEPES pH 7.5, 150 mM 
NaCl, 1 mM CaCl2, and 1 mM MgCl2) for 1 hour at room temperature with moderate 
shaking. The suspensions were washed three times with 20 mM HEPES, and re-
suspended in 500 µl 20 mM HEPES. Bacteria were subjected to FACS analysis using 
FACSCanto II (BD Biosciences) flow cytometer. Data were analyzed with FACSDiva 
(BD Biosciences software).   
3.4.6 Flow Cytometry Analysis on Functionalized Surfactant Vesicles 
 100 µM ΔlgtE LOS vesicles or C12-glucose functionalized vesicles were 
incubated in 50 µl reaction buffer (20 mM HEPES pH 7.5, 1 mM MnCl2, 1 µM LgtE) 
with or without 1 mM UDP-galactose, at 30 °C for a minimum of 2 hours. The vesicles 
were centrifuged at 800 RPM for 10 minutes at room temperature, and re-suspended in 
100 µl 2% BSA. The solution was incubated for 1 hour at room temperature with 
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moderate shaking. The vesicle solutions were centrifuged again and re-suspended in 50 
µl 20 mM HEPES pH 7.5. The vesicles were incubated with ConA Alexa Fluor® 488 
conjugate in buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM CaCl2, 1 mM MnCl2, 
and 1 mM MgCl2) or with PNA Alexa Fluor® 647 conjugate in buffer (20 mM HEPES 
pH 7.5, 150 mM NaCl, 1 mM CaCl2, and 1 mM MgCl2) for 1 hour at room temperature 
with moderate shaking, followed by an overnight incubation at 4 °C. The vesicle-lectin 
complexes were subsequently washed three times with 20 mM HEPES pH 7.5. Labeled 
vesicles were subjected to FACS analysis using FACSAria (BD Biosciences) flow 
cytometer. Data were analyzed with FACSDiva (BD Biosciences software).   
3.4.7 Vesicle Integrity Assay 
100 µM ΔlgtE LOS vesicles were incubated in 150 µl reaction buffer (20 mM 
HEPES pH 7.5, 1 mM MnCl2, 1 µM LgtE, 1 mM UDP-galactose), at 30 °C for a 
minimum of 2 hours. The vesicle containing solution was then directly applied to a 
column (length 5.5 cm, diameter 1.5 cm) containing Sepharose 2B (GE Health Sciences) 
for size exclusion chromatography. The samples were run with Blue Dextran (Sigma) as 
a marker. 15 fractions of 1.0 ml were collected, with the vesicles eluting primarily in 
fractions 2 and 3.  
To confirm the presence of the vesicles, 15 µl of each fraction was mixed with 5 
µl 3x Laemmli buffer and then subjected to SDS-PAGE analysis. The fractions were run 
on a 16% Criterion™ Tris-Tricine Precast gel (Bio-Rad Laboratories Inc.). The gel was 
run at a constant current of 3 mA, on ice, for approximately 8 hours, or until the dye front 
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The previous chapter presented evidence of glycosyltransferase mediated 
oligosaccharide chemo-synthesis on functionalized catanionic surfactant vesicles. These 
observations led to hypothesis that functionalized surfactant vesicles could be used as a 
platform for high-throughput investigations of carbohydrate-active enzymes and lectin 
binding. 
Of the more than 60,000 putative glycosyltransferases in the CAZy database, the 
enzymatic activity of only a small subset has been demonstrated and characterized.75, 76 
There is an increased interest in the field of glycobiology to develop a quantitative and 
qualitative assay in which enzymatic activity can be assessed on an array of glycan 
structures. Ban et al. developed a high-throughput label-free assay in which acceptor 
glycans are covalently immobilized in monolayers on gold plates. Acceptor substrates 
were modified with azide group and were linked to the monolayer through a terminal 
alkyne group (Figure 4.1A).19 Following an enzymatic reaction, changes in the mass of 
the acceptor substrate were determined using self-assembled monolayers with matrix-
assisted laser desorption-ionization mass spectrometry (SAMDI-MS).76 This 
methodology allows for the rapid screening of diverse carbohydrate-active enzymes, 
however, the authors make the assumption that the chemical characteristics of the linker 
moiety do not have an influence on enzymatic activity. However, Lairson and coworkers 
observed that the reaction rate of N. meningitidis galactosyltransferase LgtC was reduced  
two to four- fold depending on the structure of the linker.77 Clearly, the length of the 
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linker and its ability to display the glycan acceptor in a “biologically-relevant manner” 
had been compromised. Presumably, either the density of the glycan presented, or its 
orientation in space, cannot be controlled adequately by this technique. Moreover, the 
necessity for highly specialized instruments limits the general use of the SAMDI-MS 
assay.  
   Another assay recently reported for the investigation of carbohydrate-active 
enzymes employs flow cytometry analysis and glycans covalently coupled to 
microspheres.78 For this assay, glycans are functionalized on the reducing end with a 
linker containing a terminal amine group. The functionalized glycan substrates are then 
conjugated to carboxyl polystyrene microspheres by carbodiimide-based amide coupling 
(Figure 4.1B).78 While it is possible to demonstrate the analysis of multiple enzyme 
activities simultaneously,78 functionalized microsphere synthesis is a time-consuming and 
labor-intensive process, limiting the applicability of the technique. In addition, this 
method, much like the method described above, does not allow for control of either the 
density of the glycan or the presentation of the glycan on the surface of the bead. 
Accordingly, the relevance of the results of this assay to “biologically-relevant” events 
cannot be assessed.  
These two reports highlight the necessity for the development of an array platform 
in which glycan substrates can be easily incorporated, immobilized with control of 
density and presentation of the glycan, and analyzed in high-throughput manner. The 
development of a platform for the high-throughput analysis of glycans will enhance 
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investigations of not only carbohydrate-active enzymes but also other carbohydrate 
binding proteins.   
Studies have previously demonstrated that the physical properties of catanionic 
surfactant vesicles could be exploited for the development of a novel glycomic array 
 
Figure 4.1. Methodology of glycan immobilization. A. Click chemistry reaction of alkyne 
functionalized surface with azide functionalized glycan, resulting in covalent coupling of the 
glycan to the functionalized surface. B. Carboxyl polystyrene microspheres are activated with 
EDC (N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide) forming the unstable intermediate, 
O-acylisourea, which directly reacts with primary amines. The amine-modified glycan forms 



















platform. Dowling et al. demonstrated that intact catanionic surfactant vesicles are 
immobilized by hydrophobically modified chitosan.79 The authors functionalized the 
biopolymer chitosan with aliphatic chains, and electrodeposited the functionalized 
biopolymer onto gold electrodes. The amphiphilic biopolymer interacts noncovalently 
with catanionic vesicles in solution, capturing vesicles by insertion of the hydrophobic 
tails into the vesicle bilayer (Figure 4.1C). Importantly, the authors demonstrated that the 
retained vesicles are intact and that capture could be spatially controlled.79 This study 
suggests that hydrophobically modified chitosan could serve as a tether to immobilize 
vesicles functionalized with glycoconjugates in the development of a high-throughput 
glycomic array. 
Pond et al. reported that catanionic surfactant vesicles are retained on 
nitrocellulose-coated glass slides.38 The utility of this alternative vesicle immobilization 
method was illustrated by the construction of a glycomic array prototype. The authors 
demonstrated that lectins recognized glycoconjugates incorporated into SDBS-rich 
catanionic surfactant vesicles, and that the binding profiles were influenced by 
carbohydrate density.38 The authors concluded that the vesicles remain intact and that this 
nitrocellulose-based platform could be employed in development of a high-throughput 
platform. These works provide the first experimental evidence that catanionic surfactant 
vesicles can be immobilized and remain structurally intact on a “hard” surface.  
4.2 Specific Aims and Results 
The aim of this work is to demonstrate that functionalized catanionic vesicles are 
an ideal platform for high-throughput investigations of carbohydrate-active enzymes and 
glycan binding proteins. The data presented herein provide evidence that LgtE enzyme 
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kinetics are equivalent on LOS presented on a whole cell to that of LOS presented on a 
catanionic surfactant vesicle.  
4.2.1 LgtE Transferase Activity 
 The SDS-PAGE analysis presented in the previous chapter indicates that LgtE 
may have a higher transfer efficiency on LOS functionalized catanionic vesicles 
compared to LOS presented in a whole cell background. To quantitatively determine the 
validity of this observation, the binding parameters of the enzyme’s in vitro activity on 
whole cell N. gonorrhoeae F62ΩEcoRI LOS were determined, and compared to LgtE 
activity on LOS functionalized vesicles. To accomplish this aim, a series of western blot 
analyses were performed using the monoclonal antibody 2-1-L840 to quantify product 
formation. This technique was chosen over other biochemical assays because of the 
exquisite substrate specificity of the antibody. It was apparent from flow cytometry 
analysis, presented in the previous chapter, that there are numerous glycosylated species 
expressed on the surface of whole cell bacteria. Depending on structure, each of these 
species could potentially be modified by LgtE, and consequently lead to misinterpretation 
when comparing the catalytic efficiency on whole cells to functionalized catanionic 
surfactant vesicles. Utilization of the western blot technique facilitated the discrimination 
of LOS from other glycosylated membrane macromolecules.   
 Enzymatic transferase activity could be determined from an in vitro reaction assay 
adapted from Musumeci et al.80 The reaction was allowed to proceed under steady-state 
conditions, in which the donor substrate, UDP-Galactose, was added at saturating 
concentrations. The enzyme’s cofactor, manganese (Mn2+), concentration was carefully 
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controlled to ensure linear enzyme reaction velocity, but limiting the concentration so as 
to not disrupt the electrostatic forces that maintain catanionic vesicle stability. To 
establish this critical concentration of manganese, turbidity studies of the vesicle solution 
were performed as a function of manganese concentration (Figure 4.2A). This assay, 




      
 
Figure 4.2. Steady-state conditions for in vitro activity assay. A. Surfactant vesicle stability 
with varying concentrations of MnCl2. The spike in absorbance, which indicates an increased 
light scattering at 7 mM MnCl2, is indicative of vesicle disruption with subsequent 
precipitation. B. SDS-PAGE time course analysis of 1.5 µM LgtE in vitro activity on whole 
cell LOS. Control LOS structures are indicated. Formation of the glycosylated product is 
indicated by the appearance of a higher molecular weight band at the later time points (black 
arrow). C. Relative glycosylation product band intensity as a function of time.  
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increase in turbidity, which in turn is proportional to the extent of vesicle aggregation. 
Moreover, a time course analysis was performed to establish the optimal time point at 
which the enzyme catalyzed reaction’s initial velocity is linear with respect to enzyme 
concentration and time (Figure 4.2B and 4.2C).  
 The data in figure 4.2A indicate that the vesicles are stable in conditions up to 5 
mM MnCl2. Accordingly, subsequent kinetic studies were conducted at 5mM MnCl2. The 
time course depicted in figure 4.2B and quantified in 4.2C indicates that a reaction with 
1.5 µM LgtE, at the time point of 30 minutes, is linear with respect to time. Therefore, 30 
minutes was chosen for steady-state kinetic analysis. Based on the linearity of figure 4.2C 
at this point, it can be assumed that at an enzyme concentration of 1.5 µM, LgtE is 
saturated with substrate and the rate of product formation is directly proportional to the 
initial velocity of the enzyme-catalyzed reaction. Under these conditions, the reaction is 
considered to be in steady-state. This relationship of product formation to reaction 
velocity is the basis of the Michaelis-Menten equation. The Michaelis-Menten equation 
can be applied to describe a single site enzyme catalyzed reaction shown as: 
  
          (Scheme 4.1) 
The enzyme velocity (vo) equals the amount of product produced per unit time. Based on 
our model, vo =k2[ES]= kcat[ES], where [ES] is the concentration of enzyme bound to 
substrate and kcat is the catalytic turnover rate. Therefore, [ES] governs the rate of the 
reaction. [ES] in turn is governed by two factors: the rate of ES formation (=k1[E][S]) and 
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the rate of ES breakdown   (=k-1[ES]+k2[ES]). For the steady state assumption to hold 
true, the rate of ES formation must equal the rate of ES breakdown: 
𝑘1[𝐸][𝑆] =  (𝑘−1 + 𝑘2)[𝐸𝑆]  
          (Equation 4.1) 
Thus, for the enzyme reaction to be at steady-state, the condition of [S]total>> [E]total must 
be true. At time points on the linear part of the graph (Figure 4.2C), such as from 10-60 
minutes where the rate of [ES] change is equal to zero, the rate of product formation is 
directly proportional to time. Under constant [ES], i.e. steady-state conditions, it can be 
assumed that the reaction is not inhibited by such factors as substrate depletion, 
production inhibition, or enzyme inactivation, simplifying kinetic analysis.  
 After determining the steady-state parameters, enzymatic activity was assayed. To 
ensure that the observed concentration of product formation accurately reflected LgtE 
activity and was not an artifact of loading, the volume of the acceptor substrate added to 
the reaction mixture was held constant while varying the total reaction volume. All other 
reactant concentrations were adjusted accordingly. Additionally, to correct for any 
variations in antibody binding, a standard curve of F62Δ8-1 LOS was probed 
simultaneously and under the same conditions as each experimental blot, the signal 
detected from the blots was then normalized to the standard curve. 
 Figures 4.3 and 4.4 depict the progression of LgtE galactosyltransferase activity at 
varying concentrations LOS presented as an integral component of the bacterial cell 
membrane or incorporated into surfactant catanionic vesicles, respectively. Band 








Figure 4.3. Activity of LgtE on whole cell N. gonorrhoeae F62ΩEcoRI. A. Western blot 
analysis of the in vitro glycosylation assays. The observed signals correspond to the formation 
of L8+ glycoform (detected by the MAb 2-1-L8) B. Plot of LgtE activity as a function of 
acceptor substrate concentration. Values reflect the average of 3 independent experiments.  
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Figure 4.4. Activity of LgtE on ΔlgtE LOS functionalized catanionic surfactant vesicles. A. 
Western blot analysis of the in vitro glycosylation assays. The observed signals correspond to 
the formation of L8+ glycoform B. Plot of LgtE activity as a function of acceptor substrate 
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4.2.2 Interfacial Catalysis 
 LgtE is a peripheral membrane protein in vivo, and while the enzyme-membrane 
dynamics have not been fully elucidated, the enzyme is thought to be transiently 
associated with the membrane via pairs of dibasic residues in the C-terminus.12, 15, 39  
Based on the knowledge that lipooligosaccharide is synthesized on a lipid carrier in the 
inner membrane39 it is reasonable to assume that in vivo LgtE must first form a complex 
with membrane prior to participating in LOS biosynthesis. Therefore, the catalytic 
behavior of LgtE may in part be determined by the organization and dynamics of enzyme 
at the inner membrane: cytosol interface, and as such LgtE catalysis should be described 
by an interfacial catalysis kinetic model.81 
  Interfacial catalysis involves a series of steps that require consideration to 
elucidate a complete kinetic description.81, 82 The simplest model incorporating each step 
of interfacial catalysis is illustrated in figure 4.5. Based on the model, LgtE in the 
aqueous phase (E) binds to the interface (E*). The intrinsic equilibrium interfacial 
binding step is described by the equilibrium dissociation constant, KS. The bound enzyme 
then forms the Michaelis complex (E*S) with surface exposed LOS, described by the 
 
Figure 4.5. Model of LgtE interfacial catalysis. E: enzyme (LgtE); S: substrate (ΔlgtE 
terminal LOS); P: product (ΔlgtA terminal LOS). During steady state the enzyme in the 
aqueous phase (E) is in equilibrium with the enzyme at the interface (E*). Figure adapted 




interfacial Michaelis constant, KM
*. LgtE subsequently mediates galactosyl group transfer 
(E*P) described by the maximal velocity per enzyme molecule, kcat. The glycan can then 
be further modified by downstream enzymes. 
 While figure 4.5 allows for an appreciation of the increased complexity of 
interfacial catalysis by incorporating an interfacial binding step, the dynamics of the 
enzyme-membrane complex must also be considered in order to completely describe the 
kinetics of LgtE catalysis at an interface. Enzyme dynamics can be described by one of 
two models depicted in figure 4.6. If the enzyme “hops” from vesicle to vesicle during 
catalysis, the rate of desorption and adsorption of the enzyme from the interface will be a 
part of the overall rate of catalytic turnover, complicating kinetic studies (Figure 4.6A). 
If, however, the enzyme remains tightly anchored to the vesicle, the enzyme operates in a 
“processive” mechanism in which multiple catalytic cycles take place prior to enzyme 
dissociation (Figure 4.6B). This processive mechanism is referred to as “scooting mode.” 
In the scooting model, the kinetics of interfacial binding step (E to E*) are not considered 
in the overall steady state reaction kinetics, simplifying kinetic analysis. 
 For simplicity, LgtE can be assumed to adhere to the scooting mechanism 
depicted in figure 4.6B. This assumption is reasonable based on the relatively similar 
structural features of the interfacial binding domain of LgtE and phospholipase A2, a 
well-studied interfacial catalyst.81, 82 LgtE is presumed to associate with the inner 
membrane via the C-terminus, which contains numerous non-polar and basic residues, 
both of which may contribute to the stabilization of the enzyme: membrane complex.12, 15 
The structure of phospholipase A2 also contains a region of non-polar and basic residues, 
the interfacial recognition site, however this region is located at the N-terminus of the 
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enzyme structure.83 Therefore, based on structural similarity of the interfacial binding 
domain, the kinetic model in figure 4.5, can be analyzed in the steady-state to give the 
rate of product formation.82  
 However, in order to investigate this steady-state reaction under initial velocity 
conditions, a number of assumptions must be made. The first assumption is that either the 
binding/dissociation of enzyme to interface is slow, or that the individual surfactant 
vesicles are not in flux with free surfactant in solution, such that ES from figure 4.5 is not 
in equilibrium with E*S. Based on this assumption, the only steady-state fluxes that occur 
are in the chemical reaction, and therefore kcat is the rate-limiting step. With this 
assumption in mind, the expression for the rate of product formation per enzyme 
molecule can be derived;82 
 
Figure 4.6. Hopping and scooting model describing enzyme dynamics in a membrane. The 
enzyme is depicted in blue. A. Hopping mechanism. B. Scooting mechanism. Figure adapted 






















          (Equation 4.2) 
where KS is the dissociation constant for the substrate in the interface, kcat and kcat
aq 
describe the maximal velocity per enzyme molecule at the interface and in the aqueous 
phase respectively, Kd describes the equilibrium dissociation constant for the substrate, 
and KM and KM
* describe the apparent Michaelis constants in the aqueous phase and at 
the interface, respectively. Note that the concentration of the substrate [S*] is expressed in 
mole fraction because this concentration represents the concentration of substrate that E* 
sees at the interface, not the concentration of S in the bulk phase, [S], expressed in 
molarity (M). 
 Here kcat and KM
* account for all the kinetic constants that involve reactions at the 
interface, and similarly kcat
aq and KM in the aqueous phase, also 





          (Equation 4.3) 
Where k-1 is described in equation 4.1 and  
𝐾𝑀




 (Equation 4.4) 











where the reaction velocity at the interface, VM








The apparent Michaelis constant, KM
app, which incorporates both the reaction at the 












And the reaction velocity on the substrate in bulk solution, Vmono, which is in equilibrium 










app, Vmono, and KM
app are determined from curve fitting of initial rate vs [LOS] in 
figures 4.3 and 4.4 to equation 4.5.82 
 The reaction progress curves in figures 4.3 and 4.4, however, could not be 
reasonably fit to equation 4.5 (Appendix A4 and A5), rather the shape of the curves 
reflected the standard Michaelis-Menten enzyme kinetics (Scheme 4.1), indicating that 
the interfacial binding step (KM
*) does not contribute to the steady state rate of LgtE 
catalysis. Nonlinear regression fit to the standard Michaelis-Menten equation is 
confirmed to be reasonable based on the goodness of fit, r2> 0.94 for the whole cell 




Our model, describing LgtE as a freely diffusible enzyme in solution (Figure 4.7), 
is corroborated by prior investigations into the unique properties of the catanionic vesicle 
system.36, 84 Specifically, CTAT/SDBS vesicles, with a molar excess of SDBS in the 
outer leaflet, are extremely stable for long periods of time. Stability was assessed by 
monitoring the hydrodynamic radius of vesicles in solution, which is a good indicator of 
structural rearrangements.84 Danoff et al. conducted dynamic light scattering (DLS) 
experiments to determine the hydrodynamic radii of catanionic vesicles at different time 
points and with buffers of different ionic strength.84 SDBS-rich vesicles were determined 
to have a hydrodynamic radii of 70 ± 25 nm. However, following size exclusion 
chromatography (SEC) purification the hydrodynamic radii increased to 98 nm,84 and the 
measured radii remained consistent for at least two months.32 This lack of deviation from 
the initial time point indicates that the vesicles are equilibrium structures, i.e. there is a 
stabilizing balance of attractive hydrophobic forces of the alkyl tail groups and the 
repulsive electrostatic forces of the polar head groups. Further, the authors observed that 
catanionic vesicles efficiently capture and retain cationic dyes for up to 2 months, without 
any measurable leaching.84 Taken together these results suggest that the additive 
attractive hydrophobic and repulsive electrostatic interactions stabilize the unilamellar 
 
Figure 4.7. Proposed model of LgtE catalysis, in which there is no interfacial binding step. 
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vesicle structure despite changes in the solvent environment. Therefore, LgtE 
intercalation into the bilayer is unlikely as it is predicted to disrupt vesicle stability. 
Further supporting our model, the ionic strength of the reaction buffer may 
influence the electrostatic interactions of the dibasic C-terminus residues of LgtE and the 
outer monolayer of the vesicle membrane, which has a zeta potential of approximately     
-50 mV.32 The reaction buffer consist of 20 mM HEPES pH 7.4, and 5 mM MnCl2 (see 










                               (Equation 4.9) 
 
where ci is the concentration of the ionic species, i, and zi is the valence of the ion. The 
total ionic strength of the solvent (I) is the sum of the all the ions in solution. From 
equation 4.9, the ionic strength of the reaction buffer is determined to be 10 mM. Ions in 
solution will screen the charges on the enzyme and the vesicle respectively, reducing the 
distance over which the attractive electrostatic forces are significant. The Debye length, 
κ-1, describes the range and magnitude of these electrostatic interactions. For a 2:1 
divalent ion such as Mn2+ at a total concentration, of 5mM at 30 °C, the Debye length, 





                              (Equation 4.10) 
where εo is the permittivity of free space, ε is the dielectric constant of the medium, kB is 
the Boltzmann constant, T is the temperature in Kelvin, NA is the Avogadro number, and 
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e is the elementary charge. The screening length of the LgtE reaction buffer is 3.1 nm. As 
a result, when LgtE is more than 3.1 nm away from the vesicle surface, electrostatic 
attractive forces become negligible. Considering that the average carbon-carbon bond in 
the glucose ring is approximately 0.15 nm,86 it can be reasonably assumed that the 
surface exposed LOS molecules extend to a distance at which the electrostatic forces 
between the two molecules is reduced (Figure 1.9). Moreover, negatively charged KDO 
sugars and phosphorylethanolamine (PEtN) modification of LOS inner core residues may 
also attenuate the attractive electrostatic force between the enzyme and the vesicle 
surface.  
 Based on previous evidence describing the unique stability of the catanionic 
vesicle system, and taking into consideration the screening effects of the buffer, LgtE 







for the simple enzyme catalyzed reaction scheme: 
            (Scheme 4.1) 
If the binding of S to E is rapidly reversible relative to catalysis, i.e. k-1 >> k2, Km is 











which is the mathematical expression for the thermodynamic dissociation constant (KD). 
KM therefore, under conditions where k-1 >> k2, represents a measure of affinity of an 
enzyme for a substrate. In cases where k-1 ≤ k2, the KM is greater than the dissociation 
constant, and the experimentally determined KM is only an approximate measure of 
affinity.  
  The kinetic parameters presented in table 4.1 indicate that the KM of the LgtE 
catalyzed reaction is increased approximately eightfold on LOS presented on 
functionalized catanionic surfactant vesicles as compared to LOS presented in a whole 
cell background. Further, the kcat/KM is increased approximately fivefold, supporting the 
data presented in the previous chapter that indicated that LgtE catalyzed LOS 
modification occurs more efficiently on vesicles as compared to whole cell bacteria. The 
observed increase in activity may be a result of the inherent heterogeneity of whole cell 
bacterial membranes, which is in sharp contrast to the homogeneity of the vesicle surface. 
The three-dimensional macromolecular structure of LOS is dynamic, a consequence of 
the numerous hydroxyl groups and the free rotation permitted about the glycosidic 
bond.87 Weak interactions between LOS and integral proteins of the bacterial cell 
membrane, mediated by electrostatic forces, hydrogen bonding, and hydrophobic 
interactions, can modulate LOS conformation and therefore also influence the efficiency 
of enzymatic modification. Functionalized surfactant vesicles only incorporate LOS into 
the outer membrane, reducing the probability that LOS presentation will be altered by 
these noncovalent interactions. Therefore, the probability that LOS will be presented in 
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an accessible conformation for LgtE recognition is greater for LOS functionalized 
catanionic vesicles, than in whole cell membranes. 
4.2.3 Proof of Principle: Functionalized Catanionic Vesicle- Based Glycomic 
Array 
 To investigate the feasibility of exploiting LgtE and other recombinant enzymes 
in developing a glycomic array, we utilized a technology advanced by the DeShong 
group.37 Neeraja Dashaputre in the DeShong lab demonstrated that functionalized 
vesicles are retained on electrodes coated with hydrophobically modified chitosan (HM-
chitosan), and that the vesicles could be visualized by microscopy on this platform. 
Figure 4.8 depicts the experimental set up. Initially, the electrodes were prepared by 
printing gold onto silicon wafers in a specific pattern (Figure 4.8A). HM-chitosan was 
then electrodeposited on the electrodes such that a thin film coated the surface of the 
electrode (Figure 4.8B step 1). The enzymatic reaction with LgtE and ΔlgtE terminal 
LOS functionalized vesicles was performed in solution, and then I spotted the reaction 
mixture onto the HM-chitosan coated electrode (Figure 4.8B step 2). Product formation 
was detected by the monoclonal antibody 2-1-L8, which is specific for the lactosyl α-
chain LOS structure (Figure 4.8B step 3). Finally the presence of bound monoclonal 
Acceptor KM  (µM) kcat  (1/min) kcat/KM  (1/min*µM) 
ΔlgtE Whole Cell LOS 18 ± 2  
 
75 ± 2 
 
4.3 
ΔlgtE LOS vesicles 2.4 ± 0.5 
 
50 ± 3 
 
20.4 
TABLE 4.1. Kinetic parameters of LgtE catalyzed LOS modification. Values reflect the 








Figure 4.8. Schematic of the preparation of carbohydrate microarrays using HM-chitosan and 
SDBS-rich functionalized vesicles. A. Representation of the electrode. The yellow represents 
the printed gold surface on which HM-chitosan is electrodeposited. Blue areas represent the 
silicon wafer on which a specific pattern of gold is printed. B. Preparation of the electrode. 
Step 1: HM-chitosan is electrodeposited onto the gold surface via a pH dependent mechanism. 
Step 2: HM-chitosan inserts aliphatic chains into the catanionic vesicle bilayer, absorbing 
intact vesicles on the surface. Step 3: The surface of the vesicles is probed with the primary 
monoclonal antibody. The presence of the bound primary antibody is detected by a 
fluorescently labelled secondary antibody. Step 4: Electrodes were visualized under a 
fluorescent microscope C. Chemical structure of HM-chitosan. The n-dodecyl tails were 
covalently attached to the amine groups of chitosan via reductive amination (Figure adapted 
from Dr. Neeraja Dashaputre’s dissertation). 
















               C. 
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 Figure 4.9 presents the results of the experiment outlined in figure 4.8B. I 
visualized the electrodes on a fluorescent microscope (see experimental methods for 
more detail) and the representative images of each condition are shown. Figure 4.9C 
demonstrates that incubating ΔlgtE LOS functionalized vesicles with the purified enzyme 
enhances antibody binding above the background signal observed in figure 4.9B.  
Figure 4.9C confirms that LOS-functionalized catanionic vesicles are retained by 
the amphiphilic biopolymer, and that chemo-enzymatic synthesis is achieved. Figure 4.9 
also demonstrates that glycan binding proteins specifically recognize functionalized 
catanionic surfactant vesicles. Importantly, the data builds on previous studies providing 
experimental evidence for the utility of glycan-functionalized surfactant vesicles as a 
platform in investigations of carbohydrate-active enzymes and glycan binding proteins.  
   
   
Figure 4.9. Visualization of LgtE mediated, catalytic modification on functionalized vesicles 
by fluorescently labelled antibodies. From left to right, A. Positive control: ΔlgtA LOS 
functionalized vesicles B. Negative control: ΔlgtE LOS functionalized vesicles C. Reaction 
electrode: ΔlgtE LOS functionalized vesicles coated on the electrode. 1.5 μg purified LgtE, 
UDP-galactose, together with reaction buffer are spotted on the coated electrode and 
incubated overnight at 30 °C. D. Brightfield image of electrode. The arrows indicate the right 
angle formed by the stem of the electrode. 
 









 Carbohydrate-active enzymes are among the most abundant biocatalysts found in 
nature. However, their functional characterization has been limited, in part, due to the 
lack of a platform that allows for the characterization of a variety of enzymes on a diverse 
array of acceptor substrates. The data presented above demonstrate that glycans 
incorporated into catanionic surfactant vesicles are modified by a recombinant 
glycosyltransferase with similar efficiency as glycans presented on whole cell bacteria. 
This result is surprising, but can be explained by the physical properties of the catanionic 
surfactant system. In particular, functionalized SDBS-rich catanionic surfactant vesicles 
possess a zeta potential that is equivalent to the phospholipid bilayer of a Gram-negative 
bacterium. Therefore, the acceptor glycan is presented in background that mimics the in 
vivo environment in which the acceptor substrate encounters the glycosyltransferase. 
Additionally, the data outlined in this chapter suggest that the bioavailability of the 
substrate is enhanced when presented on the surfactant vesicle.  
Based on the kinetic parameters defined above, functionalized catanionic 
surfactant vesicles are ideal platforms for characterization of carbohydrate-processing 
enzymes. Further, data presented herein, demonstrating the retention and screening of 
functionalized vesicles on a “hard” surface, supports the utility of these vesicles in 
constructing a high-throughput array. This work represents a significant step towards the 
development of glycomic array technology and will facilitate future investigations not 
limited to the characterization of carbohydrate-active enzymes, but also into the binding 




4.4.1 Time Course LOS SDS-PAGE Analysis 
 Whole cell gonococcal LOS was prepared from plated cultures as described by 
Hitchcock and Brown74 and diluted 1:25 in 3x Laemmli buffer. The suspension was 
heated to 65 °C for a minimum of 10 minutes. Reactions and vesicles were diluted and 
heated in the same manner. 20 µl of each sample were loaded onto a sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel. After electrophoresis, the 
gel was fixed overnight in a solution of 40% ethanol- 5% acetic acid and then oxidized in 
0.83% periodic acid for 5 minutes. The gel was washed for 2 hours in multiple changes of 
H2O every 20 minutes, stained for 5 minutes in silver staining solution (22.5 mM NaOH, 
0.42% NH4OH, 47 mM AgNO3), and rewashed for 2 hours in multiple changes of H2O 
every 20 minutes. The gel was developed (100 ml of 0.005% citric acid-0.007% 
formaldehyde) until bands became visible.  
 A digital image of the gel was obtained on a flatbed scanner. Subsequently, the 
gel was analyzed with ImageJ software (Rosband W. U.S. National Institutes of Health, 
Bethesda, MD. http://imagej.nih.gov/ij/).   
4.4.2 Enzymatic Assays 
 The concentration of the acceptor substrate present on the surface of both vesicles 
and on whole cells was determined indirectly by the exoglycosidase activity of β(14) 
glucosidase (from almonds Sigma-Aldrich, St. Louis, MO). The glucosidase reaction was 
allowed to go to completion overnight at 37 °C.  
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 The concentration of liberated glucose was then determined with a glucose 
oxidase assay kit (Sigma-Aldrich, St. Louis, MO). This quantitative, enzymatic assay 
determines the amount of glucose present in a solution via glucose oxidation to gluconic 
acid and hydrogen peroxide by glucose oxidase. The hydrogen peroxide byproduct reacts 
with o-dianisidine in the presence of peroxidase to form a pink colored product. The 
intensity of the color is quantified on a UV/Visible spectrophotometer (Ultrospec 2000, 
Pharmacia Biotech) at 540 nm and is proportional to the original glucose concentration. 
Thus, by comparison to a standard curve the concentration of glucose cleaved by β(1     
4) glucosidase from the surface can be inferred. 
 Purified LgtE enzyme concentration was calculated based on absorbance readings 
by a Nano-drop UV/Visible spectrophotometer (Thermo Fischer Scientific, Wilmington, 
DE). The extinction coefficient, 23045 M-1 cm-1, of the enzyme was calculated in water 
based on the amino acid sequence (ExPASy, SIB Swiss Institute of Biotechnology).   
 LgtE galactosyltransferase activity was determined in reaction buffer (20 mM 
HEPES [pH 7.5], 1 mM UDP-α-D-galactose, 5 mM MnCl2) containing 1.5 µM LgtE and 
40, 20, 10, 5, 2.5, 1.25, 0.75, and 0 µM ΔlgtE LOS incorporated into functionalized 
vesicles, or 480, 240, 120, 60, 30, 15, 7.5, and 0 µM ΔlgtE LOS expressed on the surface 
of F62ΩEcoRI whole cells. To normalize for SDS-PAGE visualization, the volume of the 
reaction mixture was varied such the total volume of the donor substrate remained the 
same for each concentration point. The reaction mixtures were incubated at 30 °C for 30 
minutes and then terminated by adjusting the reaction mixture volumes to a single 
maximum volume, followed by centrifugation and re-suspension in 20 µl of 3x Laemmli 
buffer. 10 µl aliquots were then subjected to SDS-PAGE analysis. Following SDS- 
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PAGE separation, LOS were electro-transferred onto Immobilon-P membrane (EMD 
Millipore Corp., Billerica, MA.) in a Tris-Tricine-methanol buffer (10 mM Tris [pH 8.3], 
10 mM Tricine, 20% methanol) at a constant voltage of 100 V for 20 minutes. The 
membrane was then incubated in buffer (1x PBS, 0.05% Tween-20, 5% dry milk) to 
block nonspecific sites. The monoclonal antibody 2-1-L8, previously described by 
O’Connor et al.,40 served as the primary antibody, and was incubated with the membranes 
for a minimum of 1.5 hours at room temperature. Following a second block step, bound 
antibody was detected by incubation with horseradish peroxidase-conjugated goat anti-
mouse IgG (H+L) (Jackson ImmunoResearch Laboratories, West Grove, PA) for a 
minimum of one hour at room temperature. The intensity of signal corresponding to 
product formation was quantified by ImageJ software at each substrate concentration. 
The amount of product formation was calculated, per time unit and µM LgtE, from a 
standard curve of known concentrations of ΔlgtA terminal LOS structures blotted 
simultaneously. The experimental data were fit to obtain Vmax and KM using GraphPad 
Prism version 6.0 for Windows considering a Michaelis-Menten model (GraphPad 
Software, Inc., La Jolla, CA, www.graphpad.com)  
4.4.3 Vesicle Visualization on HM-Chitosan Coated Electrode 
Dr. Neeraja Dashaputre of the DeShong group prepared the electrodes. Briefly,        
chitosan of medium molecular weight (190-310K) and Brookfield viscosity of 286 cps 
was purchased from Sigma-Aldrich, which had a degree of deacetylation about 80%.  It 
was dissolved in 0.2 M acetic acid (pH < 6.5).  Hydrophobically modified (HM) chitosan 
was prepared by reductive amination of chitosan with dodecylaldehyde by the method 
reported in her dissertation.37 The degree of hydrophobic modification was 2.5 mol % 
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based on monomer. The method involves the following steps. Chitosan (2.00 g) was 
dissolved in 100 ml water, and glacial acetic acid was added drop wise (0.2 ml with 
stirring). The resulting suspension was stirred for 16 h.  Ethanol (100 ml) was added to 
this solution and stirred for 15 min.  Dodecyl aldehyde (0.057 g) dissolved in 5 ml 
ethanol was added to the chitosan solution drop wise, while stirring the chitosan solution 
vigorously. After 30 min, a solution of 0.78 g of NaCNBH3 dissolved in 10 mL ethanol 
was added thrice (2.34 g total) at intervals of 2 h. The solution was stirred for 24 h after 
the final addition of NaCNBH3.  NaOH (100 ml, 0.1 M) was added to neutralize the 
solution. Formation of a white precipitate was observed as NaOH was added.  NaOH (15 
ml of 1 M) was added drop wise to complete precipitation of HM chitosan. The resulting 
precipitate was washed with water until the pH of the supernatant was pH 7, and 
dissolved in 0.2 M acetic acid. The solution was poured onto non-stick baking pans and 
dried for 3 days to cast films of HM chitosan. HM chitosan was dissolved in water, with 
drop wise addition of acetic acid to prepare 1 wt % solution (pH 5.5). Later synthesis of 
HM chitosan involved drying the HM chitosan directly without dissolving it in acetic 
acid. This resulted in a better control of pH of HM chitosan solution, thus resulting in 
better, more even electrodeposition of HM chitosan. Fluorescently-labeled chitosan and 
HM chitosan were obtained from Professor Gregory Payne’s lab. These were synthesized 
by reacting the polymers with NHS-fluorescein, as previously reported in the literature.38 
100 µM LOS functionalized vesicles were incubated in reaction buffer (20 mM 
HEPES pH 7.5, 1 mM MnCl2, 1 µM LgtE) with or without 1 mM UDP-α-D-galactose, at 
30 °C for a minimum of 2 hours. Subsequently, the reaction mixture was spotted onto the 
functionalized electrodes, and then washed 3 times with 1x PBS pH 7.2. Monoclonal 
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antibody 2-1-L8 was then applied to the electrodes for a minimum of one hour. 
Following a wash step, Alexa Fluor® 568 goat anti-mouse IgG (H+L) antibody 
(Molecular Probes®) in 20 mM HEPES pH 7.5 was applied to the electrode. A final 
wash step was performed and the electrodes were visualized on a Zeiss Axio Imager.Z1 
fluorescent microscope (Carl Zeiss) through a EC Plan-Neofluor 10x objective in bright 
field and fluorescence using filter set 43HE (excitation wavelength 550/25 nm and 
emission wavelength 605/70 nm; Zeiss). Photographs were taken with a mounted 















Chapter 5: Conclusions and Prospectus 
 
 From xenotransplantation to vaccination,88 to more recently the treatment of 
traumatic brain injury,89 glycosylation is increasingly recognized as a critical component 
of pharmacology and an essential consideration in clinical innovations. Glycan-
functionalized catanionic surfactant vesicles are an established platform for investigations 
into carbohydrate binding proteins, and more recently are being utilized for targeted drug 
delivery and vaccine development.88 The work of this dissertation presents novel 
applications for functionalized catanionic surfactant vesicles. First, I demonstrate that 
under the appropriate conditions, surfactant vesicles can be utilized for enrichment of 
insoluble species associated with cell membranes, such as bacterial glycosyltransferases. 
In conjunction with our collaborator’s unpublished data demonstrating the ease and 
efficiency by which surfactant molecules can be separated from proteins and LOS 
incorporated in vesicles, this novel application of catanionic vesicles has the potential of 
facilitating macromolecule purification from membrane structures. 
Second, this study presents a novel demonstration of Neisseria 
glycosyltransferase LgtE activity on whole cell LOS. While in vitro activity of the 
enzyme has been previously demonstrated, previous reports utilized free LOS, which 
lacks true physiological relevance. Subsequently, LgtE activity was demonstrated on 
LOS functionalized and C12-glucose functionalized catanionic surfactant vesicles by flow 
cytometry analysis. The data presented in chapter three is the first report utilizing flow 
cytometry techniques to assess enzymatic modification of functionalized catanionic 
surfactant vesicles.  
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 This study also expands on previous work demonstrating the utility of 
functionalized catanionic surfactant vesicles in investigations of ligand recognition and 
catalysis by glycan binding proteins.19, 32 The data presented in chapter three demonstrate 
that enzymatic activity of a galactosyltransferase is maintained in the presence of 
catanionic vesicles, and that the galactosyltransferase activity is not limited to glycans of 
bacterial origin. Moreover, as discussed in chapter four, the kinetics of glycan enzymatic 
modification is modestly improved on catanionic vesicles as compared to whole bacterial 
cells. Based on the data presented in chapters three and four, glycan-functionalized 
catanionic surfactant vesicles may serve as a platform expediting, for example, the 
synthesis of inhibitors to galectin-3 (gal-3), a lectin that recognizes beta-galactoside 
terminating glycoconjugates and has an active role in cancer progression and 
metastasis.90 This example of vesicle utility is particularly promising as studies conducted 
by the Stein and DeShong groups indicate that the catanionic surfactant vesicles can be 
modified to target hyper-proliferative cells (Dr. Lenea H. Stocker’s dissertation). 
Therefore, this work could be expanded such that specific recombinant 
glycosyltransferases biosynthesize carbohydrates of known structure, in vitro, on 
catanionic vesicles. These vesicles could subsequently be administered as part of a 
chemotherapy regime (Figure 5.1).  
Finally, this dissertation provides the basis for a variety of future technological 
advances in the field of glycomics. Specifically, by providing evidence of the utility of 
catanionic vesicles as a platform for the development of a glycomic array to profile the 
human glycome. Data is presented in chapter four indicating that following enzymatic 
modification, vesicles are retained on a “hard” surface and that the modified glycans are 
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bioavailable, as demonstrated by differential antibody binding. This data, together with 
the FACS analysis in chapter three, confirms that functionalized catanionic vesicles have 
the potential to serve as a scaffold to probe differential lectin or antibody binding. 
The clinical implications of the data presented in chapters three and four are 
significant. According to the American Cancer Society, in 2014 alone there will be an 
estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the United 
States. It is well established that altered protein glycosylation in cancer cells is a key 
characteristic of malignant transformation.91, 92 Within the field of cancer research, there 
is a great interest to exploit the cancer glycome as source of biomarkers. However, the 
discovery of disease markers has been limited by the inherent diversity and complexity of 
 
Figure 5.1. Galectin-3 overexpression mediates tumor metastasis and proliferation. A. Gal-3 
activation recruits Ras+GTP to the plasma membrane inducing downstream signaling. 
Ultimately, expression of the transcription factor c-Myc is increased, leading to increased 
cellular proliferation and tissue invasion. B. The work of this dissertation may lead to the 
synthesis of glycans that selectively inhibit gal-3 activation, potentially reducing the incidence 
of metastatic disease.  
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tumor specific glycans, and a lack of quantitative techniques to detect subtle changes in 
glycan structure.92 Recent evidence presented by Fry et al. and  Blixt et al. has 
reinvigorated the idea that lectin or antibody profiling, respectively, could be utilized to 
detect tumor specific antigens and determine disease progression.92, 91  Fry and colleagues 
employed a commercially available lectin microarray glass slide as a platform, and 
applied formalin-fixed paraffin-embedded metastatic and non-metastatic breast tissue, as 
well as serum and urine from patients with metastatic breast cancer to the slide, to 
investigate lectin binding profiles (Figure 5.2).92 The authors concluded that there are 
subtle distinctions in the glycan expression profile of metastatic and non-metastatic breast 
cancer, and a lectin microarray could be used to detect these glycan biomarkers. There 
are limitations to this methodology, however, a consequence of covalently coupling 
lectins to slides. Significantly, structural flexibility may be restricted and the orientation 
of the immobilized lectins is random, both of which influence lectin binding properties.92 
Blixt et al. took a different approach toward investigating the cancer glycome. 
Previously, it was reported that there is a positive correlation of the mucin-type O-glycan 
Tn (GalNAcα1-O-Ser/Thr) in primary tumors with lymph node metastasis.92 Moreover, 
 
Figure 5.2. Lectin microarray profiling of cancer tissue. A. Covalently coupled lectins are 
immobilized on a glass slide. In the process of immobilization, the orientation of the coupled 
lectins is random, which may result in discrepancies in the observed binding profiles. B. 
Metastatic tissue, urine, or serum from patients with breast cancer are applied to the slide, and 
a glycomic profile is obtained. 
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the authors found that the sera of patients diagnosed with breast, ovarian, and rectal 
cancer all demonstrated reactivity with immobilized peptides expressing the Tn antigen.91 
Expanding on the work of Blixt et al., the data presented in this dissertation demonstrate 
that recombinant glycosyltransferases chemo-enzymatically synthesize structurally 
defined glycans on the surface of functionalized catanionic surfactant vesicles. 
Catanionic vesicles, therefore, have the potential to serve as a novel platform for the 
immobilization of diverse glycan biomarkers onto an array platform, which could be 
probed by a patient’s serum or urine for identification of tumor specific antibodies, 
autoantibodies associated with autoimmune diseases, or to determine an individual’s 
antibody titer (Figure 5.3).91 Further, this dissertation demonstrates that the presentation 
of glycans on the vesicle surface does not influence protein binding, indicating that the 
proposed methodology circumvents the limitations inherent to lectin microarrays. 
Chemo-enzymatic synthesis is a desired means of obtaining glycan-based antigens, as 
numerous studies have highlighted the heterogeneity of glycan expression in vivo, 
complicating simple isolation techniques.44,93 The methodology proposed in figure 5.3, 
 
Figure 5.3. The work of this dissertation provides proof-of-concept that catanionic surfactant 
vesicles along with recombinant glycosyltransferases can be utilized to develop diagnostic 
tool for immunoprofiling. Step 1 (not shown): glycosyltransferases modify functionalized 
vesicles, biosynthesizing glycans of defined structure. Vesicles are applied and retained in 
wells of a microtiter plate, coated with HM-chitosan (step 2). Serum is applied (step 3), and 




therefore, has the potential to provide a patient with a quick and reliable diagnosis and to 
provide an indication of disease progression.  
Currently, progress in the field of glycomics is limited by the absence of a standard 
platform on which glycans can be modified and investigated. Based on the work outlined 
in this dissertation, glycan-functionalized catanionic surfactant vesicles should be 
considered to fulfill this role. In conclusion, catanionic surfactant vesicles are a novel 
platform that could serve as a transformative tool for probing protein-glycan interactions 

















Appendix 1: Characterization of N. gonorrhoeae Strain F62ΩEcoRI 
 
        
 
Figure A1. A. Confirmation that the Ω interposon of pLgtDEΩEcoRI is located in the expected 
region. Lane 1: Lambda DNA ladder, digested with BstEII. The molecular weights are indicated 
on the left side in kilo-base pairs (kb). Lane 2: Undigested supercoiled pLgtDEΩEcoRI. Lane 3: 
pLgtDEΩEcoRI digested with EcoRI for ~2.5 hours at 38 °C. The Ω cassette liberated from the 
plasmid has an electrophoretic profile, as expected, of approximately 2082 kb. The digested 
plasmid has the expected profile of approximately 4 kb, and the residual undigested plasmid can 
be observed as the largest molecular weight band. Lane 4: Lambda DNA ladder, digested with 
BstEII. B. Verification of the proper insertion of the Ω cassette. Lane 1: Lambda DNA ladder, 
digested with BstEII. Lane 2: PCR amplification of N. gonorrhoeae strain F62 chromosomal 
DNA using a forward primer that binds within the Ω cassette at approximately 780 base pairs, 
and the reverse primer DA5, which binds 858 base pairs into the lgtE coding sequence. The 
resultant amplicon is expected to be 1638 base pairs. The additional lower molecular weight 
bands are most likely the result of aberrant primer binding due to the high degree of sequence 
homology within the lgtBE genes.  
 


















Appendix 2: 15% Tris-HCl SDS-PAGE of 8M urea solubilized LgtE (complete gel) 
 
Figure A2. Coomassie Blue stain of 15% Tris-HCl SDS-PAGE analysis. From left to right: Lane 
1- Kaleidoscope protein ladder Lane 2- Uninduced supernatant; Lane 3- Uninduced pellet; Lane 
4- 30 °C induction supernatant; Lane 5- 30 °C induction pellet; Lane 6- 37 °C induction 
supernatant; Lane 7- 37 °C induction pellet; Lane 8- Lysing buffer alone; Lane 9- Supernatant 
under denaturing conditions (8M urea added prior to sonication); Lane 10- Lysing buffer alone; 
Lane 11- Pellet under denaturing conditions; Lane 12- Lysing buffer alone; Lane 13- 1:10 
Uninduced supernatant; Lane 14- Lysing buffer alone; Lane 15- Pellet under non-denaturing 
conditions; Lane 16- Lysing buffer alone; Lane 17- Pellet from non-denaturing conditions re-
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Appendix 3: Calculation of Interfacial Catalysis Parameters 
 
Figure A3. Equation 4.5 from text as a user-defined equation in GraphPad Prism. Vmax 
represents VM
app; Km represents KM
app; X is the substrate concentration at the interface in mole 





Appendix 4: Nonlinear Regression of Kinetic Rates on Whole Cells Using Interfacial 
Catalysis Model 
 
Figure A4. Tabulated results of fitting the whole cell reaction initial rates versus [LOS] to 
equation 4.5. Note the wide confidence intervals and ambiguous fit. The 95% confidence interval 
describes a range of values which may reasonably contain the true value. The confidence 
intervals reflect the precision of the fit, in other words the likelihood that if the data were obtained 
under the same conditions that the same values of VM




Appendix 5: Nonlinear Regression of Kinetic Rates on Vesicles Using Interfacial 
Catalysis Model 
 
Figure A5. Tabulated results of fitting the vesicle reaction initial rates versus [LOS] to equation 











Figure A6. A. Residual plot of the nonlinear regression fit of LgtE activity on the surface of 
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